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Abstract 
The current gold standard for treatment of mandibular segmental defects is the 
use of autologous, cancellous bone grafts(Ekholm et al., 2006). These autografts 
possess excellent osteoconductive and osteoinductive properties. However, 
autografts have associated donor site morbidity including haemorrhage, infection, 
insufficient transplant integration, insufficient graft revitalization, limited availability 
and the need for a second operative site(Reichert, Epari, et al., 2010). The preclinical 
and clinical evidence for the application of newly developed tissue engineered 
constructs (TEC) in mandibular segmental defect reconstruction remains unclear and 
has not yet undergone sufficient rigorous scientific investigation to warrant 
widespread adoption(Bell & Gregoire, 2009; Carter, Brar, Tolas & Beirne, 2008b; 
Glied & Kraut, 2010b).  
An effective standardized and systematic approach in large animal studies 
investigating novel approaches to healing critical-sized mandibular segmental defects 
has yet to be established.  We propose that sheep provide the most advantageous 
large animal model for translational studies to assess safety and efficacy of novel 
TEC in healing a mandibular segmental defect. To ascertain viability and assess the 
nuances of a large segmental mandible sheep model (LSMSM), a pilot study was 
performed creating a 22mm-25mm bicortical osteotomy involving the 
parasymphyseal (diastema) region of the mandible in Merino Ovis Aries. Sheep were 
randomly assigned into two groups receiving either medical grade polycaprolactone 
(PCL) scaffold or an empty defect with no scaffold. To achieve stability across the 
defect, clinically relevant 2.4mm titanium mandible reconstruction plates (Synthes 
UniLock, Australia) were employed, primarily due to robustness and ubiquitous use 
both in the literature and clinic for fixation of large mandibular segmental defects in 
humans(Carter, Brar, Tolas & Beirne, 2008a; Clokie & S·ndor, 2008; Glied & Kraut, 
2010a; Herford & Boyne, 2008a). Unfortunately premature fracturing of 9 out of the 
12 fixation plates resulted in an early sacrifice timepoint. The defect site and 
surrounding tissue was extracted from 5 scaffold and 2 empty defect groups and 
assessed histologically for early signs of bone regeneration and an inflammatory 
response.  
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Results revealed an organised fibrous tissue network present from the initiation 
of the inflammatory response phase of wound healing, even in an unstable fracture 
environment and the scaffold appeared to provide the framework for an organised 
cellular response from an early stage with increased osteoid production and bone 
mineralisation.  
Whilst the pilot study was concluded prematurely the framework for relevant, 
reproducible data sets was successfully established. The study verified that a 
standardized large segmental mandible sheep model (LSMSM) is effectual and offers 
the suitable framework from which additional experimentation and evaluation of 
novel TEC’s may be undertaken, compared and collated.  This will provide the 
necessary data sets required in the assessment of current and future novel approaches 
to mandible segmental defect reconstruction that may be transferable to the human 
condition and, ultimately, the operative table. 
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Chapter 1: Introduction 
The human mandible is the largest and strongest bone of the face occupying a 
position of prominence and vulnerability, supported by surrounding musculature on a 
hinge joint(Gray, 2000). As a consequence, it is the second most commonly fractured 
bone of the maxillofacial skeleton(Singh, Mohapatra & Kumar, 2010). The mandible 
is unique, being the only movable load-bearing bone of the skull that is required to 
withstand the forces transmitted during function(Wong, Tideman, Kin & Merkx, 
2010). It plays an integral role in mastication, speech and defines facial structure 
whilst providing the supportive framework for soft tissues of the anterior 
laryngopharynx and assisting airway patency.   
 
 
Figure 1: Human Mandible (Photos courtesy of Dr Katherine Cunneen) 
 
Mandible bone loss can occur following fractures, infections, tumour 
resections or congenital abnormalities. This can lead to a critical-sized defect of the 
mandible, is a segmental bone defect that cannot bridge spontaneously or shows less 
than 10 percent bony regeneration and requires surgical intervention (Hollinger & 
Kleinschmidt, 1990). These bone defects are destructive, causing significant 
impediment to normal function and aesthetics as well as being technically difficult to 
reconstruct(Hollinger & Kleinschmidt, 1990; Schmitz & Hollinger, 1986). Further 
development and optimization of the surgical management of mandibular bone 
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defects is crucial to improving outcomes and decrease patient morbidity. Tissue 
engineering continues to pioneer novel and exciting approaches to restoring, 
replacing and regenerating injured or diseased biological tissue(Chan & Leong, 
2008).  
In the field of craniomaxillofacial surgery several biosynthetic bone 
supplements are already approved for human clinical use to treat mandibular bone 
defects. Whilst these biosynthetic supplements have provided additional therapeutic 
options, the current gold standard for treatment of bony defects remains autologous, 
cancellous bone grafts(Ekholm et al., 2006). These grafts possess excellent 
osteoconductive and osteoinductive properties, although they are hindered by donor 
site morbidity including haemorrhage, infection, insufficient transplant integration, 
insufficient graft revitalisation, limited tissue availability and the need for a second 
operative site(Reichert, Epari, et al., 2010). In addition, the failure rate of autologous 
bone graft is up to 30%(Gautschi, Frey & Zellweger, 2007). These complications are 
avoidable and provide the rationale for research into viable therapeutic alternatives 
that eliminate the need for a second operative site and provide effective management 
at the initial operative intervention to improve patient outcome, limit patient 
morbidity and avoid the need for re-intervention(Gautschi et al., 2007). The pursuit 
of a viable alternate in the management of mandibular critical-sized bone defects is 
thus of significant clinical implication.  
The myriad of approaches employed in investigating mandibular defect bone 
regeneration has resulted in many animal models and case-reports but often with a 
lack of depth and reproducibility in scientific data sets. Currently, preclinical and 
clinical evidence for more widespread indications and applications of newly 
developed tissue engineering techniques is unclear and has not yet undergone 
sufficient rigorous scientific investigation to warrant widespread adoption(Bell & 
Gregoire, 2009; Carter et al., 2008b; Glied & Kraut, 2010b). For novel tissue 
engineering approaches in mandible segmental defect regeneration to be translated 
from the bench top to the bedside requires vigorous in vivo interrogation via a well-
designed and validated preclinical animal model. 
 
Establishing an animal model is a necessary step in the study of in vivo 
mandibular bone healing to provide clarification and scientific acumen for the most 
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efficient and effective therapeutic option to treat bone defects(Nunamaker, 1998). A 
standardised systematic approach, employing a reproducible preclinical animal 
model with consistent post-explantation analysis, investigating novel approaches to 
healing critical-sized mandibular defects, has yet to be established. A reproducible 
animal model is the necessary step in the study of in vivo mandibular bone 
regeneration constructs to provide clarification and scientific acumen for the most 
efficient and effective therapeutic option.  In addition, establishing an effective 
model will generate a framework for further studies into the wide-ranging 
implementation of tissue engineered construct’s (TEC). The ability to construct 
polycaprolactone (PCL) with fusion deposition modelling may result in customized 
scaffolds prepared to the defect specifications. This provides a myriad of options for 
therapeutic application from larger defects, including hemi- or full mandible 
reconstructions to embedding with growth hormones and stem cells to assist 
regeneration in difficult clinical scenarios including post radiotherapy, poorly 
vascularised tissue. These extraordinary but achievable goals will provide the 




A variety of animal models have been employed in the investigation of 
mandibular defect regeneration, ranging from small animal models to larger animals 
including dog, pig, sheep and non-human primates. Whilst these studies provide an 
increasing volume of data there has yet to be consistency in developing a 
standardized systematic approach to evaluating mandibular defect regeneration. 
What is lacking is a standardised large animal model that more effectively mimics 
the human condition and wound healing environment and employs consistent 
standardisation of in vivo application and post-explantation analysis to investigate 
tissue engineering approaches for reconstructing mandibular critical-sized 
defects(Muschler et al., 2010). Establishing this model is essential so that the 
innovative approach to mandibular bone regeneration, when applied to clinical 
practice, is both reliably efficacious and maintains appropriate patient safety.   
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1.2 CONTEXT 
To present a viable therapeutic alternative for mandibular defect regeneration 
via a tissue engineered construct (TEC) requires building a reliable and reproducible 
body of research data. The data sets can then be compared and collated to further 
develop the TEC so that it may be transferable to the human condition and, 
ultimately, the operative table. To translate research from the bench-top to the 
bedside necessitates the foundation of a large animal model with a standardised 
evaluation process prior to implementation in the clinical setting(Berner et al., 2012; 
Muschler et al., 2010). Whilst this can be expensive and time consuming, it is 
imperative that novel constructs undergo rigorous scientific evaluation prior to 
implementation. The current literature on translational research of mandibular defect 
regeneration includes a variety of animal models that have been employed to 
investigate novel approaches to mandibular defect regeneration. Whilst these studies 
provide an increasing volume of data there has yet to be neither a reproducible model 
nor a standardized systematic approach to evaluating mandibular bone regeneration. 
Ideally, the preclinical animal model should emulate clinical surgical 
techniques, provide appropriate tissue size and handling that would be encountered 
clinically, be versatile in a controlled environment and allow quantitative assessment 
of results(Cheng et al., 2005). In addition animals with comparable bone architecture 
and remodelling rates to humans will provide greater accuracy in extrapolating data 
and making predictions about the potential clinical success or failure of novel tissue 
engineering approaches(Muschler et al., 2010; Reichert, Epari, et al., 2010; Reichert 
et al., 2009a). Through a review of the current literature and an established 
experience with sheep tibial defect studies we propose that the sheep model will 
provide the necessary framework for collating and comparing data sets for novel 




The purpose of this study is to review the current animal model research in 
bone regeneration techniques for mandibular bone defects and provide a line of 
reasoning for employing sheep as the preclinical translational model. In addition, a 
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pilot study was performed to provide guidelines for the large segmental mandible 
sheep model (LSMSM) in vivo investigation and post-explantation analysis of novel 
approaches to mandibular bone defects.  
The research problem is that there has yet to be a consistent systematic 
approach to animal studies of the in vivo application of mandibular defect 
regeneration. The safety evidence for more widespread indications and applications 
of newly developed tissue engineering techniques is unclear and has not yet 
undergone sufficient rigorous scientific investigation to warrant widespread 
adoption(Bell & Gregoire, 2009; Carter et al., 2008b; Glied & Kraut, 2010b). It is 
believed that sheep will provide the best model for translational research; however, 
stable fixation of the bony defect site has provided an impediment that must be 
overcome prior to progression of further research 
. 
1.4 SIGNIFICANCE, SCOPE AND DEFINITIONS 
Ultimately the objective is to provide and implement a viable, efficacious 
alternative to bone regenerative fixation of a critical-sized mandibular defect that will 
provide both therapeutic advantages and improve patient outcome whilst decreasing 
patient morbidity. Establishing an effective model will generate the framework for 
further research comparing novel approaches to large segmental mandible defects 
and solving complicated therapeutic problems ranging from even larger segmental 
mandible defects to bone regeneration in a difficult clinical setting such as a tumour 
model with post-irradiated, poorly vascularised tissue.  
 
1.5 THESIS OUTLINE 
This Masters thesis will review the current literature on animal models for 
novel regeneration of mandibular bone defects and endeavour to provide a line of 
reasoning in favour of establishing a preclinical sheep model in the application and 
analysis of novel tissue engineered constructs (TEC). It will determine whether or 
not the sheep model provides the most suitable large animal model from which 
additional experimentation and evaluation of TEC’s for healing mandibular defects 
may be undertaken, compared and collated.  It is hypothesized that the consistent 
 6 Chapter 1: Introduction 
application of a large segmental mandible sheep model (LSMSM) will provide a 
valuable framework in the assessment of a variety of novel TEC’s so that they may 
be transferable to the human condition and, ultimately from bench to bedside. 
Based on this background a pilot study was performed to ascertain the viability 
and nuances of the sheep mandibular segmental defect model consisting of a 22mm-
25mm bicortical defect within the parasymphyseal diastema region of the mandible 
in Merino Ovis Aries. In the absence of an established critical-sized defect for 
Merino Ovis Aries, the defect size was determined intra-operatively as the greatest 
distance available involving the diastema region without the prior removal of a 
premolar tooth. Two sheep groups were randomly assigned to either the control 
group, with an empty defect, or to the scaffold group with polycaprolactone (PCL) 
scaffold. Premature fracturing of the mandibular reconstruction fixation plates 
unexpectedly occurred. This presented an opportunity to uniquely analyse the early 
stages of the host response to a polycaprolactone (PCL) construct in vivo, which, to 
our knowledge, has not been previously performed. Histology and 
immunohistochemistry findings reinforced the biocompatible nature of the scaffold. 
They further highlight the importance of the scaffold system in providing a platform 
for cells promoting a regenerative pathway, such as osteoblasts and fibroblasts, to 
result in organised fibrous tissue deposition, a decreased immune response and 
enhanced bone mineralization potential compared to that of the empty defect group.  
Future prospects for this study involve the resolution of the plate fixation 
system in repair of a bicortical bone defect in sheep mandible model. This is 
imperative for further evaluation of regenerative repair. Whether the solution is a 
thicker fixation plate or an innovative plate fixation design, it will require additional 
scrutiny prior to implementation, including biomechanical testing currently being 
undertaken in our group.  
Establishing an effective model will generate the framework for further 
research comparing novel approaches to large segmental mandible defects and 
solving complicated therapeutic problems ranging from even larger segmental 
mandible defects to bone regeneration in a difficult clinical setting such as a tumour 
model with post-irradiated, poorly vascularised tissue.  
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Chapter 2: Literature Review 
2.1 CLINICAL CONTEXT AND HISTORICAL BACKGROUND 
The human mandible is the largest and strongest bone of the face occupying a 
position of prominence and vulnerability, supported by surrounding musculature on a 
hinge joint(Gray, 2000). As a consequence, it is the second most commonly fractured 
bone of the maxillofacial skeleton(Singh et al., 2010). It plays an integral role in 
mastication, speech and defining facial structure whilst providing the supportive 
framework for soft tissues of the anterior laryngopharynx and airway patency. The 
mandible is unique, being the only movable load-bearing bone of the skull that is 
required to withstand the forces transmitted during function(Wong et al., 2010). 
Bone loss following fractures, infections, tumour resections or congenital defects can 
lead to critical-sized defects of the mandible.  
Critical-sized defects are defined as “the smallest size intraosseous wound in a 
particular bone and species of animal that will not heal spontaneously during the 
lifetime of the animal”(Schmitz & Hollinger) or as a defect which shows less than 10 
percent bony regeneration during the lifetime of the animal(Hollinger & 
Kleinschmidt, 1990). These defects are destructive, causing significant impediment 
to normal function and aesthetics as well as being technically difficult to 
reconstruct(Hollinger & Kleinschmidt, 1990). Thus, enhancement and optimization 
of the clinical management of mandibular defects is essential. In the field of 
craniomaxillofacial surgery several biosynthetic bone supplements are approved for 
the use of sinus augmentation and also alveolar ridge augmentation associated with 
extraction sockets(Davies & Ochs, 2010; Lo, Ulery, Ashe & Laurencin, 2012).  
The current gold standard for treatment of continuity mandibular defects is the 
use of autologous, cancellous bone grafts(Ekholm et al., 2006). These autografts 
possess excellent osteoconductive and osteoinductive properties. However, 
autografts have associated disadvantages such as donor site morbidity including 
hemorrhage, infection, insufficient transplant integration, insufficient graft 
revitalization, limited availability and the need for a second operative site(Reichert, 
Epari, et al., 2010). In addition, the failure rate of autologous bone grafts is up to 
30% and thus it is imperative any defect should be treated correctly at the outset to 
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avoid the need for re-intervention(Gautschi et al., 2007). Clinically, the limitations of 
autologous bone grafting include; inadequate quantity and quality of bone, potential 
graft failure and the morbidity of a second operative site(Boyne, 1997; Schmidmaier, 
Capanna, Wildemann, Beque & Lowenberg, 2009).  
This has led to a search for alternative treatment modalities and substitutes that 
restore facial form, speech, function and occlusion thus returning the patient to 
normal oral function and providing a better quality of life(Bak, Jacobsen, Buchbinder 
& Urken, 2010; Schrag, Chang, Tsai & Wei, 2006). These substitutes include the 
successful use of autologous vascularized fibula, scapula, iliac crest, and rib 
transplant(Cheng, Brey, Ulusal & Wei, 2006; Clokie & S·ndor, 2008; Deschler & 
Hayden, 2000; Disa & Cordeiro, 2000; Ferretti & Ripamonti, 2002; Forriol et al., 
2009; Herford & Boyne, 2008a; Kahairi, Ahmad, Wan Islah & Norra, 2008; Kelley, 
Klebuc & Hollier, 2003; Moghadam, Urist, Sandor & Clokie, 2001; Peled, El-Naaj, 
Lipin & Ardekian, 2005; Terheyden et al., 2001; Warnke et al., 2004; Werle, Tsue, 
Toby & Girod, 2000). Despite the success rates of these vascularized free flaps they 
still possess disadvantages to the patient and clinician with long operative times and 
donor site morbidity. (Bak et al., 2010; Bodde, de Visser & Duysens, 2003; Boyne, 
1997; Daniels, Thomas, Bell & Neligan, 2005; Schmidmaier et al., 2009) Hence, a 
growing interest in the application of tissue engineering to reconstruct segmental 
mandibular defects has arisen to negate the disadvantages associated with current 
techniques.  
 
Warnke et al employed a novel approach to avoid a secondary bone defect with 
the successful creation of a custom vascularised bone graft within the patient’s 
latissimus dorsi muscle. Transplantation was carried out 7 weeks after the initial 
surgery, harvesting the newly formed bone, latissimus dorsi muscle and the 
associated vasculature of the bone-muscle flap. This bone-muscle flap was then 
transplanted into the same patient’s mandibular defect utilizing a extraoral 
approach(Warnke et al., 2004). This obviated the use of a second operative site with 
the associated risks. In this case the patient developed a number of complications 
several weeks and months after the surgery. In addition to vascularised free tissue 
transfer, the use of guided bone regeneration with distraction osteogenesis has also 
been employed as an alternative to bone augmentation(Kilic et al., 2011). 
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Bioimplants and distraction osteogenesis has shown promise in both animal trials and 
in selected patients with benign disease and short segmental defects.(Chao, Donovan, 
Sotelo & Carstens, 2006; Chin, Ng, William & Carstens, 2005; Clokie & S·ndor, 
2008; Ferretti & Ripamonti, 2002; Herford & Boyne, 2008b; Herford, Boyne, 
Rawson & Williams, 2007; Schuckert, Jopp & Teoh, 2009) Whilst distraction 
osteogenesis avoids the complications associated with a second surgical site, the 
technique requires tremendous patient compliance and is prone to infections 
(Schroeder & Mosheiff, 2011). Attempts to overcome the limitations of a second 
operative site and it’s associated morbidity lead to several case reports involving 
reconstruction of mandibular continuity defects. These case reports were carried out 
in the clinical setting with varying results using tissue constructs with or without 
Bone Morphogenetic Protein-2.(Abukawa et al., 2004; Cheng et al., 2006; Clokie & 
S·ndor, 2008; Ferretti & Ripamonti, 2002; Gautschi et al., 2007; Herford & Boyne, 
2008a; Kahairi et al., 2008; Moghadam et al., 2001; Reddi, 2001) However, the 
authors were inconsistent in their approach to patient care. Currently, the safety 
evidence for more widespread indications and applications of newly developed tissue 
engineering techniques is unclear and has not yet undergone sufficient rigorous 
scientific investigation to warrant widespread adoption(Bell & Gregoire, 2009; 
Carter et al., 2008b; Glied & Kraut, 2010b).  
 
The myriad of approaches to mandibular defect bone regeneration and the lack 
of scientific data highlight the need for a well-designed and validated preclinical 
animal model. This model will provide the framework for reproducible scientific 
acumen involving an appropriate tissue engineered construct (TEC) as well as 
applicable angioinductive and osteoinductive factors, for extrapolation and clinical 
application of tissue engineering techniques. A variety of animal models have been 
employed in the investigation of mandibular defect regeneration, ranging from small 
animal models to larger animals including dog, pig, sheep and non-human primates. 
Whilst these studies provide an increasing volume of data sets there has yet to be 
consistency in developing a standardized systematic approach to evaluating 
mandibular defect regeneration. What is lacking is a standardised large animal model 
with consistent in vivo application and post-explantation analysis to investigate tissue 
engineering approaches for reconstructing critical-sized mandible defects. 
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Establishing this model will provide scientific rigor and confidence in a viable 
alternative to current clinical practice that is both reliably efficacious and maintains 
appropriate patient safety.   
 
2.2  ANIMAL MODELS 
Scaffolds designed for bone reconstruction have been progressively developed 
through the interdisciplinary collaboration of medicine, science and engineering and 
continue to be refined. The use of a preclinical animal model is a necessary step in 
the study of in vivo bone healing. It provides scientific acumen for the most efficient 
and effective way to treat clinical conditions(Nunamaker, 1998). The model plays a 
crucial role along the developmental spectrum of regenerative medicine from 
establishing the foundations of bone healing of TECs, to assessing their feasibility 
and bioactivity for clinical implementation(Muschler et al., 2010). Thus, animal 
models provide the necessary link between in vitro investigations to clinical 
implementation, from the bench top to the bedside. Animal models range from small 
animals such as rodents and rabbits, to larger animals including dogs, sheep and 
nonhuman primates.  
The choice of animal model is important. Each model possesses beneficial 
attributes as well as unfavorable features. Animal selection should therefore be based 
on a number of criteria. Foremost, the model should be able to fulfill the 
requirements of the research question and be suitable for operative intervention, 
employing a similar technique to that of the human clinical setting. In addition, 
practical considerations including cost, animal availability, ethical acceptability, 
tolerance to captivity, and ease of housing need to be addressed(Pearce, Richards, 
Milz, Schneider & Pearce, 2007). It should be noted that the results obtained from 
the use of animals must be interpreted within the context of inter-species disparity 
prior to human application as animals of a lower phylogenetic order have, on 
average, a higher potential for spontaneous bone regeneration(Salmon & Duncan, 
1997). This advocates the use of a large animal model for in vivo investigation with 
employment of an appropriate control arm. Though costly, large animal experiments 
are necessary to replicate the limited vascular supply and slower bone healing 
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observed in humans and higher mammals compared with that of small 
animals(Runyan & Taylor, 2010). 
 
2.2.1 Small Animals 
The advantages small animal models provide for investigating tissue 
engineering constructs is that they are easy and inexpensive to house, easily 
maintained and possess fast bone turnover rates(Mooney & Siegel, 2005; T. et al., 
2011). Furthermore, small animal breeding cycles are far shorter than large animals, 
providing larger study sizes to assess healing of bony defects. Due to these 
advantages, small animal studies have been used by several authors to investigate 
TECs in healing mandibular defects.(Kahnberg, 1979; Mooney & Siegel, 2005; 
Schliephake et al., 2009) Unfortunately, study designs have been inconsistent in 
employing appropriate control arms for the critical-sized mandibular defects in these 
small animal models(Nunamaker, 1998; Schliephake et al., 2009). Anatomically, 
small rodents are disadvantageous, as they not only possess a more primitive bone 
structure without a haversian system, but are technically difficult to perform 
operative intervention due to the diminutive size of the mandible and intricacy of 
operative access.(Hollinger & Kleinschmidt, 1990) Also, their biology differs to 
humans in key aspects of bone healing. That is, they continue to model their skeleton 
throughout their lives and their growth plates remain permanently open(Muschler et 
al., 2010). However, the advantages appear to outweigh the disadvantages in small 
animal models with a continuous rise in rodent fracture healing studies in Medline-
listed publications since the 1960s.(T. et al., 2011) Thus, small animal models can 
provide a high-powered baseline proof-of-concept study prior to large animal studies 
but do not serve well to provide a model to extrapolate to the human clinical scenario 
due to their disparity in bone anatomy and healing mechanism.  
2.2.2 Rabbit 
The rabbit model has a similar profile to the rodent model being relatively 
inexpensive whilst possessing a high bone turnover rate allowing for moderate sized 
groups(Mooney & Siegel, 2005; Nunamaker, 1998).  Akin to the rodent model, they 
are beneficial for initial testing of TEC’s for bone healing in mandibular 
defects(Kahnberg, 1979; Ren et al., 2007). Unfortunately, they possess fatty marrow 
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that is distinctly different in physical properties to human marrow making assessment 
of bone healing difficult to extrapolate(Muschler et al., 2010). Also, there has been 
no standardization for the critical-sized defect with lack of an adequate control arm 
in most studies(Kahnberg, 1979; Ren et al., 2007).  Again they provide data sets for 
high-powered baseline proof-of-concept studies. 
2.2.3 Porcine 
Miniature pigs have been widely used to investigate orthopaedic and dental 
research. They possess a plexiform bone pattern which is closer in relation to human 
bone microarchitecture, physiology and biomechanical properties than 
rodents.(Reichert et al., 2009b) Like humans, they possess succedaneous dentition 
but differ with continually erupting incisors(Mooney & Siegel, 2005; Reichert et al., 
2009b). They have been successfully applied in ‘proof-of-principle’ studies to 
highlight the success of various methodologies in reconstructing mandibular defects 
such as in vitro cultured mesenchymal stem cells,(Abukawa et al., 2004) the 
application of biomatricies without osteoblasts,(Henkel, Gerber, Dorfling, Gundlach 
& Bienengraber, 2005) fabrication of vascularized bone flaps using rhBMP-2 and 
adipose-derived stem cells,(Runyan et al., 2010) and rhBMP-7 with xenogenic 
bone.(Terheyden et al., 2004) These ‘proof-of-principle’ studies provide the 
foundation required for application of scaffolds, mesenchymal stem cells and 
vascularized flaps generated by rhBMP in large animal models in the future. Despite 
the previous mandibular reconstruction studies conducted using a porcine model, 
animal models investigating critical sized mandibular defects in pigs may face 
difficulties due to recent dispute in the literature regarding critical defect size. 
(Ruehe, Niehues, Heberer & Nelson, 2009) Henkel et al established that critical sized 
mandibular defects in miniature pigs were defects greater than 5cm
3
.(Henkel et al., 
2005) That figure was superseded by Ma et al who demonstrated that critical sized 
mandibular defects in minipigs are 6cm with periosteum and 2cm without 
periosteum.(Ma, Pan, Tan & Cui, 2009) However, in a study conducted by Ruehe et 
al they found that large defects of 10cm
3 
showed 75.5% newly formed bone within 
the defect. Due to the small sample size of n=3 further investigation may be 
warranted.(Ruehe et al., 2009) Overall, handling difficulties due to their demanding 
disposition coupled with high healing rates has kept pigs from being a useful model 
in investigating fracture healing (Nunamaker, 1998; Reichert et al., 2009b). 
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2.2.4 Canine 
Canine models have been used to assess mandibular bone healing in multiple 
mandibular defect models. Numerous studies have had success at regeneration of 
segmental bone defects utilizing bone marrow stromal cells and tricalcium 
phosphate, (He et al., 2007) rhBMP-2 in a collagen sponge carrier,(Hussein et al., 
2013) bone marrow stromal cells with porous β-tricalcium phosphate(Yuan et al., 
2010) and microporous polylactide membrane combined with iliac crest bone 
graft(Sverzut et al., 2008). Defects sizes ranged from 30mm to 35mm except in the 
study by Sverzut et al. 2006, where the defects were only 10mm.(Sverzut et al., 
2008). Consensus of the critical-sized mandibular defect for the canine model is 
difficult as there is inter-breed variation in bone healing. A well-designed study by 
Huh et al. 2005, found the critical-sized mandibular defect for mongrel dogs to be 
15mm without periosteum and 50mm with periosteum(Huh et al., 2005). However 
reproducibility is difficult due to the heterogenous nature of mongrel 
breeding(Muschler et al., 2010). The canine model provides advantages for in vivo 
investigation of mandibular defects but carries disadvantages such as low non-union 
rate and a higher rate of solid bony fusion compared to humans.(Reichert et al., 
2009b) In addition, the use of canine models is beset with ethical concerns given the 
nature of their high societal regard and difficulty in handling. 
2.2.5 Nonhuman primates 
Nonhuman primates represent the closest phylogeny to humans, and have been 
employed for mandibular defect studies often with impressive regenerative 
results(Boyne, 1996, 2001; Boyne, Salina, Nakamura, Audia & Shabahang, 2006; 
Marukawa et al., 2002; Seto, Asahina, Oda & Enomoto, 2001; Seto, Marukawa & 
Asahina, 2006; Zhou et al., 2010). Despite the advantage of phylogenetic proximity, 
nonhuman primates have several drawbacks. These include the marked variation in 
response between species and the practical issues such as cost and 
availability(Muschler et al., 2010).  Similar to canines there are ethical 
considerations associated with their phylogenetic proximity to humans and societal 
regard(Muschler et al., 2010).  They also provide obstruction due to their disposition 
and handling difficulties. These obstacles have served to hinder the application of the 
primate model in bone tissue engineering. However, as Muschler et al 2010 noted, 
despite the notion that they provide a closer affiliation to human semblance there is 
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no direct evidence that nonhuman primate models are systematically or consistently 
superior to other large animal models(Muschler et al., 2010).  
 
Model Defect Size Control Arm 
Mouse 4mm round Inconsistent 
Rat 4mm segmental No control arm 
Rabbit 5mm segmental Lack of adequate evidence, only 1 
paper with a control arm 
Dog 15-50mm segmental Mongrel dog with well designed 
control arm 
Pig 20-60mm segmental  ?critical-sized as growth >10% 
control. Critical size in dispute 
Nonhuman Primates 15mm No control arm 
Table 1: Overview of Critical-Sized Mandibular Defects in Animal Models 
 
2.3 SHEEP MODEL FOR MANDIBLE 
Sheep are a suitable large animal model for research in bone healing as they 
respond well to surgical procedures and are closer in the phylogenetic order to 
humans than most other animal models (Salmon & Duncan, 1997). Sheep are not 
beset with the ethical concerns of dogs and nonhuman primates. In addition, they 
provide a mild-mannered disposition, being easy to handle pre-and post-operatively, 
when conducting operative intervention.(Reichert et al., 2009b) The mandible 
operative site is readily accessible for the creation of a defect and practical for testing 
regenerative procedures and therapy concepts, thus providing a suitable model for 
surgery with uneventful post-operative healing(Salmon & Duncan, 1997).  For 
mandible defect studies a sheep model is most advantageous as it is a large mammal 
with a mandible size similar to that of humans possessing a similar bone formation 
rate(den Boer et al., 1999; Nunamaker, 1998; Wittenberg, Mukherjee, Smith & 
Kruse, 1997). As a model for investigating tissue engineering constructs (TEC) in 
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segmental mandibular defect healing they have been widely employed and continue 
to provide a valuable tool for ongoing research in this field(Abu-Serriah et al., 2006; 
Abu-Serriah et al., 2005; Alkan, Celebi, Ozden, Bas & Inal, 2007; Ekholm et al., 
2006; Forriol et al., 2009; Kontaxis, Abu-Serriah, Ayoub & Barbenel, 2004; Martola, 
Lindqvist, Hanninen & Al-Sukhun, 2007; Nolff et al., 2010; Schliephake, Knebel, 
Aufderheide & Tauscher, 2001). However, despite their advantages sheep are 
ruminants and possess a dissimilar pattern of mastication to humans(Kontaxis et al., 
2004). This influences optimal post-operative care, as it is important that the sheep’s 
diet not remain too soft for too long a time period. Another disparity involves ovine 
dentition, which, although similar to humans by being succedaneous, differs by 
maintaining continually erupting incisors(Mooney & Siegel, 2005). Sheep also 
possess long, narrow heads and enlarged attachment sites for the masseter 
muscle(Mooney & Siegel, 2005). While the anatomy differs to that of the human 
mandible, this difference is actually of benefit as the edentulous span at the 
parasymphyseal region permits ease of operation without the need for exodontia. On 
the whole, sheep provide a valuable model in the assessment of tissue engineering 
constructs (TEC) for healing of mandibular defects, which would be transferable to 
the human condition. Whilst sheep provide a useful model for translational studies to 
investigate novel TECs for mandibular defects, consistent in vivo application and 
post-explantation analysis has not been standardised across studies(Abu-Serriah et 
al., 2006; Abu-Serriah et al., 2005; Alkan et al., 2007; Ekholm et al., 2006; Forriol et 
al., 2009; Kontaxis et al., 2004; Martola et al., 2007; Nolff et al., 2010; Schliephake 
et al., 2001). 
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Table 2: Overview of Sheep Mandible Studies 
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2.4 ESTABLISHING A MODEL 
Cheng et al surmised that, for an animal model to be of most benefit, it must 
replicate clinical surgical techniques, provide appropriate tissue size and handling 
that would be encountered clinically, be versatile in a controlled environment and 
allow quantitative assessment of results(Cheng et al., 2005). Due to the diversity of 
disease conditions and the variation in animal constitution there can be no perfect 
model that will provide the exact clinical environment to mimic the human condition.  
This is the inherent limitation of any animal model, however, it still remains 
imperative that translational studies investigating the applicability and safety profile 
of any intervention be thoroughly examined and validated prior to human 
implementation. 
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Figure 2: Road map to establishing a critical-sized bone defect study in a large animal 
model. [Adapted from (Reichert, Epari, et al., 2010)] 
 
One of the key components to evaluating TEC’s for bone healing in an animal 
model is to establish the specific critical-sized defect for that model. The 
experimental critical-sized defect for a sheep mandible depends on many factors 
related to both the sheep and the nature of the defect created. These range from age, 
breed, defect shape, defect position (inferior or superior), degree of penetration 
(unicortical or bicortical), plate and screw size, length of healing time and method of 
analysis(Salmon & Duncan, 1997). It is important that these variables be addressed 
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when establishing a model with a critical-sized defect so that results are comparable 
and may be reproducible. Unfortunately, studies performed on sheep have, to date, 
all differed in the size of their critical defect and the employment of a control arm. In 
a study by Abu-Serriah et al, a bicortical osteoperiosteal mandible continuity defect 
was performed on adult Scottish grey face sheep where it was found that a 3.5cm 
defect was critical-sized(Abu-Serriah et al., 2006; Abu-Serriah et al., 2005; Kontaxis 
et al., 2004). While in a study of adult female black headed sheep, a 2.5cm bicortical 
defect was employed for the critical size but with an insufficient control arm(Nolff et 
al., 2010).  A further study by Forriol et al 2009, employed a 6cm bony defect in the 
mandible of 15 sheep, Ovis aries, aged 8 years where reconstruction of the defect 
was carried out with allograft, frozen rib, rhOP-1, PRP, and a combination of frozen 
rib and rhOP-1(Forriol et al., 2009). This study employed a successful empty defect 
control arm at 6cm.  
To sum up the current literature it can be stated that the defect size employed 
for the critical-sized mandibular defect in adult sheep has ranged from 2.5cm to 6cm, 
and an appropriate control arm has not been employed for any defects less than 
3.5cm. The critical-sized mandibular defect has proved difficult to establish and will 
vary between sheep breed and age. An appropriate control arm is required to discern 
what is the minimal sized defect that is critical in bone healing for that particular 
sheep breed at a certain age. Following establishment of the critical-sized defect it is 
important that the surgical technique be reasonable and relevant. In addition the post-
explantation analysis must include histology, biomechanical testing and computed 
tomography scanning.  
 
The review of the current literature highlights the need to employ an 
appropriate reproducible control arm when investigating critical-sized mandibular 
defects as well a consistency of in vivo application and post explantation analysis to 
assist interpretation and correlation of results between studies. 
 
2.5 MANDIBULAR FRACTURE MANAGEMENT IN SHEEP 
The management of a mandibular bone defect in animal models is fraught with 
difficulties given the importance of the mandible in mastication and the inherent 
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nature of veterinary medicine. Management will be highly influenced by the 
temperament, compliance and ease of animal handling. However, difficulties and 
complications in managing animals post-operatively must be anticipated. Clinically, 
mandibular fracture management in humans covers the spectrum of conservative 
management to operative intervention. This includes antibiotics, analgesia, oral 
hygiene and a soft diet with immobilization to aid healing of the fracture site. Whilst 
most of these aspects of fracture management are transferrable to the sheep model, 
there remain noncompliant facets that impart obstacles to optimal management.  
Open reduction and internal fixation with plate and screws has proven to be the 
most effective method of rigid fixation in humans, associated with minimal 
morbidity and early return to function(Ajmal, Khan, Jadoon & Malik, 2007). Lack of 
adequate stabilisation leads to chronic inflammation, which impairs normal healing 
and may result in delayed union, non-union, or infection(Futran, 2008). Whilst 
dietary advice, oral hygiene, relative immobilisation and patient input regarding pain 
are cornerstones of clinical care in humans, they provide obstacles in post-operative 
management of mandibular defect repair in sheep. This is unavoidable and requires 
that appropriate intervention including altered diet and regular analgesia be 
instituted. 
 
2.5.1 Post-explantation Biomechanical Testing 
The biomechanical properties of the mandible has been studied and described 
with better understanding of the forces the mandible withstands during function and 
also the forces the reconstructed mandibles must tolerate(Wong et al., 2010).  Whilst 
reconstruction of critical-sized mandibular defects has been investigated in a variety 
of animal models, there are limited studies assessing the biomechanical properties of 
the regenerated bone.  The mandible is the only movable load-bearing bone of the 
skull that is required to withstand the forces transmitted during function(Wong et al., 
2010). Therefore, biomechanical assessment of the healed mandible post intervention 
is essential. The five ways to biomechanically assess or load a bone involve tension, 
compression, bending, shear and torsion forces. The small number of studies that 
engaged in biomechanical testing of sheep mandible, following reconstruction of a 
defect, differed in their approach. They either employed a 3-point bending test(Alkan 
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et al., 2007; Yuan et al., 2010) or cantilever forces(Abu-Serriah et al., 2005; Kontaxis 
et al., 2004).  
The shape of the mandible and its muscular and ligamentous attachments 
results in complex dynamics of the masticatory system. It involves the interplay of 
the temporomandibular joint and various ligaments attaching to the mandible, hyoid 
and styloid process. However, the dominant determinants of jaw movements revolve 
around the muscles(Koolstra, 2002). The system is mechanically redundant, with an 
infinite number of muscle contraction patterns that can cause the same movement. As 
such, the mechanical strength and the forces at play in a reconstructed mandible are 
complex and not fully understood(Wong et al., 2010). Therefore, it is important that 
an appropriate, reproducible protocol for biomechanical testing be instituted to assess 
load-displacement, stiffness and maximum applied moment for both the operated and 
non-operated side of a post-operative mandible.  In establishing a model, we propose 
to biomechanically test the mandible with cantilever test in all four planes as 
displayed in figure 2.  
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Figure 3: Biomechanical testing using cantilever force with Instron 35kN.  
The hemimandible is embedded in PMA and a distance of 11cm measured 
and marked on the hemimandible (A) and (B). The hemimandible is held 
firmly in place during loading force application and tested in the four planes 
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of craniocaudal (C), mediolateral (D), caudocranial (E), and lateromedial 
(F). 
 
2.5.2 HISTOLOGY AND COMPUTED TOMOGRAPHY 
Post-explantation histological examination will also be established in the 
analysis of bone growth within the critical sized defect of the operated mandibles.  
Histological analysis will involve paraffin and resin embedding techniques whilst 
utilizing Von Kossa and Goldner’s trichrome staining to determine calcification and 
bone growth. Immunohistochemistry will be carried out to determine the 
inflammatory reaction to the polycaprolactone scaffold as well as μCT to visualize 
mineralized matrix volume and mineral density as described in previous sheep tibial 
defect studies performed in our group(Abu-Serriah et al., 2006; Abu-Serriah et al., 
2005; Berner et al., 2013; Berner et al., 2012; Cheng et al., 2005; Hutmacher et al., 




There exists a recognized need in the literature to provide further data sets on 
the efficacy and safety profile for novel tissue engineered constructs (TEC) in 
healing mandibular segmental defects prior to their translation to clinical 
implementation. The establishment of a standardized large animal model is 
imperative in translational research of TEC’s. The standardized animal model must 
be consistent in the animal’s age and breed, to the operative technique and post-
operative care, and finally the post-explantation analysis. This will provide consistent 
in vivo application and post-explantation analysis for investigating and comparing 
TEC’s in reconstructing mandibular critical-sized defects. It will afford rigorous 
assessment of alternate techniques to current clinical practice so that they are reliably 
efficacious whilst maintaining appropriate patient safety.  
Whilst there have been a variety of animal models employed in the 
investigation of mandibular defect regeneration there has yet to be consistency in 
developing a standardized systematic approach.(Carter et al., 2008a; Clokie & 
S·ndor, 2008; Glied & Kraut, 2010a; Herford & Boyne, 2008a) The establishment of 
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a standardized sheep model provides the most suitable framework from which 
additional experimentation and evaluation of TECs for healing mandibular defects 
may be undertaken, compared and collated.  It will provide a valuable tool in the 
assessment of a variety of mandibular segmental defect TECs that may be 
transferable to the human condition and, ultimately, the operative table. 
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Chapter 3: PILOT STUDY 
3.1 INTRODUCTION 
A standardized and systematic approach to large animal studies investigating 
novel approaches to healing critical-sized mandibular segmental defects has yet to be 
established. A preclinical animal model is the necessary step for investigating in vivo 
mandibular segmental defect regeneration TEC’s to provide clarification and 
scientific acumen assessing both the efficacy and safety profile of novel TEC’s.  
Once established, the model will generate the framework for future research to 
investigate alternative approaches to solve ever more complicated therapeutic 
problems ranging from large segmental mandible defects to bone regeneration in post 
radiotherapy tissues. 
 When designing a preclinical animal model it is important to encompass the 
scope of animal research from the operative technique and post-operative 
management to the post-explantation histological analysis, biomechanical testing and 
radiographic assessment of bone regeneration. From a review of the current literature 
and enlisting prior practical experience with sheep tibial segmental defect projects, 
we propose that sheep provide the most advantageous large animal model for 
translational studies to assess the safety and efficacy of a mandibular TEC(Abu-
Serriah et al., 2006; Abu-Serriah et al., 2005; Berner et al., 2013; Berner et al., 2012; 
Cheng et al., 2005; Hutmacher et al., 2001; Reichert, Epari, et al., 2010; Reichert et 
al., 2009a; Reichert, Woodruff, et al., 2010). A pilot study was performed to 
ascertain the viability and nuances of the sheep mandibular segmental defect model 
consisting of a 21mm-25mm bicortical defect within the parasymphyseal diastema 
region of the mandible in Merino Ovis Aries. The defect size was dependent on the 
length of the sheep diastema and was determined intra-operatively. To achieve 
stability across the defect our research group employed a clinically relevant 2.4mm 
titanium mandible reconstruction plate (Synthes UniLock, Australia), primarily due 
to its robustness and ubiquitous use in the literature, to fixate large mandibular 
segmental defects in humans(Carter et al., 2008a; Clokie & S·ndor, 2008; Glied & 
Kraut, 2010a; Herford & Boyne, 2008a). 
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Sheep were randomly assigned into two groups with six sheep receiving 
medical grade polycaprolactone (PCL) scaffolds and six sheep receiving no scaffold, 
consequently having an empty defect. It was hypothesized that this pilot study would 
highlight any practical difficulties with the sheep model in providing the framework 
for establishing the large segmental mandible sheep model (LSMSM) for future 
research endeavours. The establishment of the tenets of operative technique, post-
operative management and post-explantation analysis were successful, however, 
premature fixation plate fracture occurred in 9 out of 12 sheep. The plate fixation 
system will require further investigation so as to provide stable fracture fixation prior 
to future implementation. This chapter will describe the operative and immediate 
post-operative management employed for our chosen model. 
 
3.2 MATERIALS AND METHODS 
 
3.2.1 Scaffold fabrication and preparation 
Biodegradable scaffolds comprising medical grade polycarprolactone (80 kDa) 
and β-Tricalcium Phosphate (20 kDa.) (outer diameter 10mm, height 30mm, inner 
diameter 5mm) were obtained from Osteopore (Osteopore International, Singapore). 
PCL was electropsun using an in-house device(Detta et al., 2010). All scaffolds were 
treated for 6 hours with 1M NaOH and washed five times with phosphate-buffered 
saline (PBS) prior to their operative implementation. Sterilization of the scaffold was 
subsequently performed with the scaffold placed in 70% EtOH for 5 minutes and 
under UV irradiation for a minimum of 30 minutes. 
 
3.2.2 Surgical Procedure 
 
Large Animal Model 
Merino sheep (weight 44-52kg, age 6-7yrs) underwent operative intervention 
as approved by the University Animal Ethics Committee at the Queensland 
Universirty of Technology, Brisbane, Australia (Ethics number 1000001192). The 
two experimental groups consisted of an empty defect and a scaffold only group. 
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Induction and Preparation 
The sheep were housed overnight in a communal pen. They were assessed by 
the vetinary surgeon and weighed the morning of the procedure. A 7French venous 
central line (Arrow, Teleflex®) was inserted into the jugular vein and the sheep was 
anaesthetized with intravenous induction of propofol  (4 mg/kg, IV). An endotracheal 
tube was inserted and anaesthesia maintained with 50% oxygen in air, 
and isoflurane (1%), using a mechanical ventilator.  
 
Operative Instruments 
Standard operating equipment for mandibular fixation including: Oscillating 
saw (Stryker) for creating bicortical osteotomies; Titanium mandible reconstruction 
plate (2.4mm, 10 holes, Synthes UniLock); Bicortical Titanium screws (12mm-
20mm, Synthes); Periosteal elevator; Depth gauge; and screwdriver. 
 
Operative Intervention and Timeline 
Sheep were positioned supine, following induction of anaesthesia and the 
procedure was performed under sterile conditions. The right hemimandible surgical 
site was prepared with iodine povacrylex. Sterile drapes were employed and a sterile 
operating field created.  
An 8-10cm longitudinal incision was made along the inferolateral border of the 
mid to distal mandible in the parasymphyseal diastema region. The subcutaneous 
tissue was reflected laterally and held with a retractor. The periosteum of the 
mandible was stripped circumferentially from the mental foramen to the first 
premolar, above the diastema, with a periosteal elevator.   
A titanium mandible reconstruction plate (2.4mm, 10 holes, Synthes UniLock) 
was placed on the inferolateral border of the mandible, torque neutral. All proximal 
and distal screw holes were drilled and depth measured for screw length. The plate 
was temporarily fixed either side of the proposed defect site with bicortical locking 
screws at the diastema of the mandible. The proposed defect site was marked with a 
sterile permanent marker. 
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The fixation plate was then removed and saline soaked gauze inserted between 
the bone and soft tissue to avoid damage to the tissue whilst performing an 
osteotomy. The neurovascular bundle exiting the mental foramen was ligated with 3-
0 monocryl. 
The bicortical bone defect was created via parallel osteotomies, perpendicular 
to the long axis of the bone, with an oscillating saw (Stryker) under constant 
irrigation with saline solution. Gauze, bone wax and Surgicel were applied to the 
bone marrow to achieve haemostasis. In all procedures, haemostasis was achieved. 
 
 
Figure 4: Operative Procedure.  
Incision of inferolateral right hemimandible performed under sterile 
technique (A); the periosteum is removed (B); the premolar tooth (arrow) 
and the neurovascular bundle (*) are identified (C). The site of the bony 
defect is marked (curved arrow) and the plate applied, torque neutral with 
drill holes performed through plate and fixed with screw (D); Plate removed 
(E), then an osteotomy performed and the plate reapplied (F); Scaffold cut to 
size and placed in defect (G) & (H); and finally, wound closure (G). 
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In the experimental group, the PCL scaffold was adjusted to fit the defect site 
by trimming with a scalpel to match the length of the bone defect. It was then gently, 
but firmly, placed in the defect site and the locking plate fixed. The wound was 
closed in two layers with a subcutaneous continuous suture (3-0 Monocryl) and 
interrupted skin sutures (4-0 Novafil). The skin incision was sprayed with 
oxytetracycline (Terramycin, Pfizer).  
 
Participants 
The 12 operations were performed two cases per day over six separate 
operating days with the involvement and cooperation of four surgeons. Two 
specialist maxillofacial surgeons, Dr Lynham and Dr Warnke, performed 6 of the 
operations. The remainder of the procedures were performed by either an 
experienced trauma surgeon or surgical trainee. 
 
The surgical period from induction to extubation and recovery was 
approximately 3-4 hours with operative times of 45-60 minutes. The mandibular 
segmental defect size ranged from 22mm up to 25mm, with an average of 23mm. 
The defect size was selected intra-operatively and based on the length of the sheep 
mandible diastema and after placement of fixation plate. 
















Plate Empty 1089 6 47.9kg 27.09.2011 24mm 
2.4mm AO 
Plate Empty 1048 ~6 47kg 27.09.2011 24mm 
2.4mm AO 
Plate Empty 1046 ~8 43kg 01.11.2011 23mm 
2.4mm AO 
Plate Empty 1123 ~8 38kg 01.11.2011 22mm 
2.4mm AO 
Plate Empty 1169 6 45.5kg 01.02.2012 23.5mm 
2.4mm AO 
























ld 1182 6 43kg 09.02.2012 22mm 
Table 3: Sheep operations performed for the large segmental mandible sheep model 
 
 
3.2.3 Post operative management 
 
Antibiotics and Analgesia 
Antibiotics and analgesia were administered for the first 48 hours after the 
procedure. The sheep were administered buprenorphine (Temgesic®, 0.3mg/ml) 
(0.005mg/kg, IV) and ketorolac (Toradol®, 30mg/ml)(0.5mg/kg, SC) for preventative 
and bi-modal pain management. Antibiotic prophylaxis was administered to all sheep 
post-operatively via the parental antibiotic regimen ciprofloxacin 
(200mg/100ml)(5mg/kg, IV); cefazolin (Kefzol®1gr)(20mg/kg, IV); gentamicin 
(80mg/2ml)(5mg/kg, IV).  
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Housing and Diet 
Operated sheep were housed in a separate pen to the remaining flock but with 
the other sheep that had undergone the same procedure. These sheep were placed on 
a soft diet of water-soaked pellets and Lucerne-oaten chaff for 48 hours before 
returning to the flock and a normal diet.  
 
3.2.4 Post-operative Assessment 
 
Sheep were imaged immediately following the surgical procedure and then 
monitored daily for the first 3 days post-operatively to assess feeding and activity by 
both the operating surgeon, a veterinary surgeon and animal handlers. Antibiotics 
and analgesia were administered at this time. Further lateral and craniocaudal 




Figure 5: Initial radiographs post-surgical intervention.  
All radiographs demonstrate an empty defect (*) and the plate fixation 
(arrow). 
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3.2.5 Explantation 
The scaffolds from the sacrificed sheep were explanted for 
immunohistochemical analysis. The soft tissue surrounding the mandible was 
removed and the bony mandible explanted. The mandible was divided with an 





Lateral and craniocaudal radiographs of the operated mandibles were taken two 
to three weeks after the surgical procedure. In 9 out of the 12 operated cases a 
fracture of the fixation plate was identified from the radiographs and confirmed 
clinically. The animals were euthanized by intravenous injection of sodium 
pentobarbital.  
 Chapter 3: PILOT STUDY 37 
 
Figure 6: Radiographs displaying intact and fractured 2.4mm titanium mandible 
reconstruction plates  
The 2.4mm titanium mandible reconstruction plates (Synthes UniLock) were 
inadequate fixation devices for the LSMSM with fracturing occurring at the 
proximal junction and intact titanium plates. (A) is a lateral view of the 
sheep mandible demonstrating the proximal fixation of the plate (i) and the 
segmental bony defect at the diastema of the sheep mandible (*). (B) is a 
craniocaudal view and demonstrates the segmental bony defect (*) and the 
distal fixation of the plate at the parasymphyseal region of the mandible (ii). 
(C) is a lateral view of the sheep mandible demonstration fracturing of the 
fixation plate (iii) at the junction of the proximal fixation and the empty 
segmental defect with inferior displacement of the distal segment. (D) is a 
craniocaudal view of the same fractured mandible plate (iii) with medial 
displacement of the distal segment. 
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3.3.2 Biomechanical Testing 
Biomechanical testing was unable to be performed due to premature plate 
fracturing resulting in fracture instability and the short timeframe meant the inability 
of bone bridging to occur across the critical-sized defect. However, a framework for 
biomechanical testing was established on non-operated hemi-mandible and will 
involve cantilever forces in all four planes. The unoperated hemi-mandible was 
explanted following sheep sacrifice. They were embedded in polymethyl 
methacrylate (Paladur, Heraeus Kulzer, Germany) by holding the hemi-mandible in a 
custom designed embedding block. A distance of 11cm was measured along the body 
of the mandible distal from the edge of the embedded ramus and marked. The 
hemimandible was held firmly in place by the vice of the Instron 35kN (Instron, 
Norwood, USA). Loading force application and cyclical bending stress was applied 
and tested in the four planes of craniocaudal, mediolateral, caudocranial, and 
lateromedial (data not shown). 
Formal biomechanical testing of non-operated hemi-mandibles is currently 
being performed to assess fatigue and finite element modelling. 
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Figure 7: Biomechanical testing using cantilever force with Instron 35kN.  
The hemimandible is embedded in PMA and a distance of 11cm measured 
and marked on the hemimandible (A) and (B). The hemimandible is held 
firmly in place during loading force application and tested in the four planes 
of craniocaudal (C), mediolateral (D), caudocranial (E), and lateromedial 
(F). 
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3.3.3 Histology and Immunohistochemistry 
Histology and immunohistochemistry were performed to investigate early 




Figure 8: Von Kossa Stain Overview 
(A) Von Kossa staining of a scaffold group demonstrating the proximal and 
distal native bone; (B) comparison with the intraoperative appearance of the 
scaffold in situ and; (C) Von Kossa staining of an empty defect group with 
fibrous tissue linked only to the distal native bone. 
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Figure 9: Overview of stains for the scaffold group and empty defect group  
(A) Hematoxylin and Eosin stain for scaffold group, s (scaffold), Ds (Distal end), 
Px (Proximal end), Md (medial side), Lt (lateral side). Stains B,D,F and H are from 
the proximal defect site. Stains C, E, G and I are from the scaffold strut located 
towards the distal end. J. Hematoxylin and Eosin stain for empty defect group. Stains 
K, M, O and R are taken from the proximal defect site and stains L, N, Q and S are 
from the distal defect site. (B) Positive stain for TRAP. (C) Negative stain for TRAP. 
(D) Positive stain for CD68. (E) Negative stain for CD68. (F) Some positive stain for 
ON. (G) Positive stain for ON along the scaffold strut. (H) Positive stain for OPN. (I) 
Negative stain for OPN. (K) Large positive stain for TRAP. (L) Light positive stain 
for TRAP. (M) Large positive stain for CD68. (N) Light positive stain for CD68. (O) 
Positive stain for ON. (Q) Negative stain for ON. (R) Positive stain for OPN. (S)  
Negative stain for OPN.  
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3.4 DISCUSSION:  
The surgical management of fractures of the mandible body is principally via 
open reduction and internal rigid fixation (ORIF). This allows a more rapid osseous 
repair, with return of occlusion and masticatory function as well as maintenance of 
periodontal tissue.(Korkmaz, 2007; Olate et al., 2013) An ORIF approach to human 
mandible body fractures is primarily achieved with 2.0mm and 2.4mm mandibular 
reconstruction locking or standard plates(Collins, Pirinjian-Leonard, Tolas & 
Alcalde, 2004; Korkmaz, 2007; Olate et al., 2013; Scolozzi & Richter, 2003; Shaik, 
Raju, Rao & Reddy, 2012). Evidence suggests that mandible fractures treated with 
2.0mm locking plates and 2.0mm standard plates present similar short-term 
complication rates(Collins et al., 2004; Shaik et al., 2012). Further studies of 2.4mm 
titanium reconstruction plates used to treat severe mandible fractures demonstrated a 
low rate of major complications (3%) and a high success rate(Scolozzi & Richter, 
2003). 
Thus to mimic the clinical environment and in light of the Sheep ruminant 
masticatory pattern it was decided that the more robust 2.4mm mandibular 
reconstruction plates would be employed for fixation device in a large segmental 
mandible sheep model (LSMSM). It must be noted that in the human clinical 
condition, ORIF is often employed in conjunction with maxillomandibular fixation 
(MMF) which is not feasible in the sheep model(Collins et al., 2004; Korkmaz, 2007; 
Olate et al., 2013; Shaik et al., 2012). 
The mandible provides a unique challenge in the operative and post-operative 
management of a LSMSM given the crucial role it plays in mastication. From the 
results of our pilot study it is evident the 2.4mm titanium mandible reconstruction 
plates were unable to tolerate the considerable forces generated during the 
masticatory cycle of ruminants(Martola et al., 2007). The mechanics of sheep 
mastication are such that they possess large masseter muscles and generate 
considerable degree of torque during mastication. As such, the 2.4mm titanium 
mandible reconstruction plate used in human surgery is an inadequate fixation device 
for the sheep mandible. The understandable difficulty associated with the post-
operative care of the sheep model is the inability to limit the movement of the 
mandible due to its pivotal role in mastication. The fixation plate complication was 
not anticipated from reviewing the literature, with only one author citing difficulty 
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with plate fracture and instability of a bicortical defect in the mandibular 
parasympheal region of sheep(Schliephake et al., 2001).  
Fracture of titanium fixation plates has occurred in patients who have 
undergone mandibular reconstructions and are more common among patients with a 
segmental defect that does not cross the midline and in whom no bone grafting is 
performed(Katakura, Shibahara, Noma & Yoshinari, 2004; Shibahara, Noma, Furuya 
& Takaki, 2002). 
 
 
Figure 10: Radiograph of plate fracture  
Case that was referred to Dr Lynham. Fracture occurred in the angle of the 
mandibular reconstruction plate (arrow) at the proximal end of the defect site 
(*), a similar location to that encountered in our pilot study. 
 
The cause of the fixation plate fracturing is thought to be the result of stress 
concentration, the location of which varies depending on the form of the plate, with 
frequent repeated application of stress or fatigue(Katakura et al., 2004). Evaluation 
of clinical and experimental plate fracture among cases in which primary 
reconstruction after mandibular resection employed titanium reconstruction plates 
revealed that plate fracturing was commonly in L-type defect cases in which angle-
type plates were used, and the fracture mainly occurred in the anterior region of the 
mandibular angle(Katakura et al., 2004). Often the instability at the plate fracture site 
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in a mandibular segmental defect resulted in bone graft failure(Futran, Urken, 
Buchbinder, Moscoso & Biller, 1995; Hidalgo, 1989; Mooren, Merkx, Kessler, 
Jansen & Stoelinga, 2010; Yerit et al., 2002). In addition, excessive instability at the 
defect site is not conducive to bone formation and bridging of the defect(Giannoudis, 
Einhorn & Marsh, 2007). 
 
The plate fracturing in the LSMSM occurred due to masticatory forces and led 
to instability of the defect site. This instability is not conducive to bone formation 
and bridging of the defect(Giannoudis et al., 2007). We hypothesize that thicker 
reconstruction plates coupled with longer screw lengths at the mandibular symphysis 
engaging the contralateral mandible may be able to withstand the masticatory forces 
applied to the defect, and result in greater fracture stability allowing accurate 
assessment of bone formation and bridging of the segmental defect. With the results 
of the pilot study, biomechanical testing is currently being performed on unoperated 
sheep mandibles and those with an empty defect fixated with 2.4mm titanium 
reconstruction plates, 2.8mm titanium reconstruction plates and custom stainless 
steel plates respectively. This will further evaluate the disparity in strength between 
plate systems and provide confidence in the selected plate fixation system employed 
for future surgeries.  
 
Once stability at the fracture site is accomplished, the critical sized defect can 
be established in the LSMSM and long term implantation studies pursued. The post-
operative management will involve regular clinical and radiographic review. The 
tenets of the post-explantation analysis have been well established with the sheep 
tibial model and this framework will be emulated in the mandible model(Abu-Serriah 
et al., 2006; Abu-Serriah et al., 2005; Berner et al., 2013; Berner et al., 2012; Cheng 
et al., 2005; Hutmacher et al., 2001; Reichert, Epari, et al., 2010; Reichert et al., 
2009a; Reichert, Woodruff, et al., 2010). It will involve biomechanical testing, as 
well as histological, radiographic and computed tomography analysis.  
 
 Whilst reconstruction of critical-sized mandibular defects has been 
investigated in a variety of animal models, there are limited studies assessing the 
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biomechanical properties of the regenerated bone. Studies that engaged in 
biomechanical testing of sheep mandible following reconstruction of a defect 
differed in their approach. They either employed a 3-point bending test(Alkan et al., 
2007; Yuan et al., 2010) or cantilever forces(Abu-Serriah et al., 2005; Kontaxis et al., 
2004). The dominant determinants of sheep mandible movements revolve around the 
muscles(Koolstra, 2002). The system is mechanically redundant, with an infinite 
number of muscle contraction patterns that can produce the same movement. As 
such, the mechanical strength and the forces functioning in a reconstructed mandible 
are complex and not fully understood(Wong et al., 2010). Therefore, it is important 
that an appropriate, reproducible protocol for biomechanical testing be instituted to 
assess load-displacement, stiffness and maximum applied moment for both the 
operated and non-operated side of a post-operative mandible. We propose to 
biomechanically test the mandible with cantilever force in all four planes, and this 
protocol was established on non-operated hemimandibles. 
  
Post-explantation histological analysis of bone growth within the critical sized 
defect of operated mandibles will employ paraffin and resin embedding techniques 
utilizing Von Kossa and Goldner’s trichrome staining to determine calcification and 
bone growth. Immunohistochemistry will be carried out to evaluate the 
osteoinductive and osteoconductive properties of the polycaprolactone scaffold as 
described previously in the sheep tibia models performed in our group (Berner et al., 
2013; Berner et al., 2012; Cheng et al., 2005; Hutmacher et al., 2001; Reichert, 
Epari, et al., 2010; Reichert et al., 2009b; Reichert, Woodruff, et al., 2010).  
 
Plain radiographs of in vivo scaffold will assess the stability of plate fixation 
and early callous formation and be performed at the two week, one month, three 
month and six month review or earlier if clinically a plate fracture is suspected. 
Micro-Computed Tomography (μCT) will be used to assess and visualize 
mineralized matrix volume and mineral density of the explanted segmental defect 
site as established at our institution (Berner et al., 2013).  
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In the current pilot study performed at our institution, the failure of the 2.4mm 
titanium reconstruction plates proved an obstacle to establishing the critical-sized 
defect and assessing the efficacy of our scaffold in bone regeneration of a segmental 
mandibular defect. Overcoming fixation plate fracturing must be remedied prior to 
further development of the LSMSM. It is maintained that sheep provide an excellent 
preclinical model for both operative intervention and post-operative management and 
investigation of mandibular scaffold efficacy. The brief post-operative management 
and subsequent analysis has been appropriately designed to provide results that are 
reproducible and relevant. This includes radiographic assessment, histological 
analysis and biomechanical testing. These three tenets, along with computed 
tomography, will provide the necessary data sets required to evaluate the safety and 
efficacy profile of a tissue engineered construct (TEC) prior to clinical 
implementation.  
 
Once established, the large segmental mandible sheep model (LSMSM) will 
provide the basis for further studies into the wide-ranging implementation of TEC’s. 
The ability to construct PCL with fusion deposition modelling may result in 
customized scaffolds prepared to the defect specifications. This provides myriad 
options for therapeutic application from larger defects, including hemi- or full 
mandible reconstructions to embedding with growth hormones and stem cells to 
assist regeneration in difficult clinical scenarios including post irradiated, poorly 
vascularised tissue. Through the use of a preclinical LMSM, these extraordinary but 
achievable goals will provide the inspiration to further research in innovative 
techniques for healing critical-sized mandibular defects. 
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Chapter 4: Histology:  
Short Term Mandibular Implantation of Polycaprolactone 
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4.1 ABSTRACT: 
The literature possesses a growing body of knowledge surrounding 
polycaprolactone (PCL) as a tissue engineering construct (TEC) for bone 
regeneration with much long-term implantation data available (i.e. 1 month- 5 years 
in vivo). However, the early tissue response to an in vivo PCL scaffold application 
has not yet, to our knowledge, been investigated(Ai-Aql et al., 2008; Akintoye et al., 
2008; Anderson & McNally, 2011; Athanasou & Quinn, 1990; Berner et al., 2013; 
Boyne, 1996; Carstens et al., 2005; Cipitria et al., 2012; Collin et al., 1992; Ekholm 
et al., 2006; Forriol et al., 2009; Fritz et al., 2000; Glied & Kraut, 2010a; Herford & 
Boyne, 2008a; Kahnberg, 1979; Kilic et al., 2011; Lemperle et al., 1998; Meyer et 
al., 1999; Okafuji et al., 2006; Ren et al., 2007; Shigeno et al., 2002; Tatsuyama et 
al., 2009; Wei et al., 2006; Yuan et al., 2010; Zheng et al., 2009). The initial response 
is important to understand as it influences surrounding tissue as well as the time 
taken for bone regeneration. To investigate this, 8 Merino Ovis aries (sheep) were 
operated over a two week operative interval with 6 being implanted with a 22mm-
25mm PCL scaffold in the parasymphyseal region of the mandible and the remaining 
two with an empty defect. An unexpected adverse event of premature fixation plate 
fracturing in 7 of the 8 operated sheep resulted in early sacrifice three weeks post 
implantation. The defect site and surrounding tissue was extracted from 5 scaffold 
and 2 empty defect groups and assessed histologically for early signs of bone 
regeneration and inflammatory responses using immunohistochemistry and 
conventional techniques assessing tissue morphology. Results reinforced the 
biocompatible nature of PCL based TEC and also indicated that an organised fibrous 
tissue network is present from the early tissue response phase of wound healing, even 
in an unstable fracture environment. It would suggest that the scaffold has provided a 
degree of mechanical stability and the framework for an organised cellular response 
from an early stage with a combination of both decreased inflammatory markers and 
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4.2 INTRODUCTION: 
Tissue engineering continues to pioneer novel and exciting approaches to 
restore, replace and regenerate injured or diseased biological tissue(Chan & Leong, 
2008). A critical-sized defect of the mandible is a segmental bone defect that cannot 
bridge spontaneously and requires surgical intervention(Hollinger & Kleinschmidt, 
1990; Schmitz & Hollinger, 1986). The current gold standard for therapeutic 
intervention of critical-sized defects is the use of autologous cancellous bone grafts, 
with the foremost advantage being a minimal host immune response as the graft is of 
the same tissue origin(Ekholm et al., 2006). Autologous bone grafts have associated 
disadvantages of donor site morbidity including haemorrhage, infection, insufficient 
transplant integration, insufficient graft revitalisation, limited availability and the 
need for a second operative site from the same patient(Reichert, Epari, et al., 2010). 
In addition, the failure rate of autografts is up to 30%(Gautschi et al., 2007). 
Autologous bone graft must be transported from an alternate site, usually the iliac 
crest, and for mandibular segmental reconstruction the need for a second operative 
site and limited tissue availability provide the two greatest obstacles to a successful 
outcome.  In addition to autologous bone grafting for segmental defect regeneration, 
less invasive management options include allografts, using donated tissue from bone 
banks and metallic implants. In most cases these techniques are effective, however, 
they risk infection, haemorrhage, and, in the case of metal implants and allografts, an 
immune reaction.  Thus, a clinical alternative that reduces these risks and offers a 
ready to use “off the shelf” product would be indispensable.  Tissue engineering aims 
to provide constructs that are viable therapeutic alternatives, limiting these risks and 
providing effective management at the initial operative intervention to improve 
patient outcome, limit patient morbidity and avoid the need for re-
intervention(Gautschi et al., 2007). The key components to tissue engineering are 
scaffolds, growth hormones and cells.  Scaffolds act as the extracellular matrix with 
the aim to provide the framework and structural support in facilitating the 
localisation of cell migration and organised tissue healing(Chan & Leong, 2008; 
Kim, Baez & Atala, 2000).  Effective tissue engineered scaffolds for healing critical-
sized bone defects necessitate biocompatibility, mechanical strength, porosity to 
enable nutrient exchange and vascular ingrowth as well as the ability to be rapidly 
and reliably reproduced(Dalton, Woodfield & Hutmacher, 2009). Synthetic 
biomaterials, such as polycaprolactone (PCL), are advantageous as a tissue 
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engineered construct (TEC) for bone regeneration due to their bioinert nature and 
design flexibility with the ability to manipulate their physical and mechanical 
properties and tailor the design towards bone specific regeneration(Abbah, Lam, 
Hutmacher, Goh & Wong, 2009; Chan & Leong, 2008).  
  
Mandible fracture healing is the result of a vast and intricate interplay of 
molecules and cells influenced by intrinsic and extrinsic patient dynamics, 
coordinated by molecular and intercellular interactions(Hollinger & Schmitz, 1987). 
The majority of mandible bone defects and fractures heal spontaneously, coordinated 
by a sequentially organized cell population and microenvironment determinants. If 
these coordinated events are compromised the potential for regeneration is limited, 
leading to poor wound healing with resultant patient morbidity(Anderson & 
McNally, 2011; Nguyen, Orgill & Murphy, 2009; Reichert, Woodruff, et al., 2010; 
Reichert et al., 2011).  The three phases of wound healing can be roughly divided 
into the initial inflammatory response, followed by a proliferative phase and then 
maturation. Thus bone healing commences with an inflammatory reaction in order to 
initiate the regenerative process eventually resulting in the reconstitution of 
bone(Schmidt-Bleek et al., 2012). An excessive host immune response during this 
early phase of bone healing may disrupt the normal regenerative process and delay 
healing, endangering a potentially successful outcome(Schmidt-Bleek et al., 2012). 
The nature of the initial host immune response is dependent upon the host’s 
physiology and the nature of the insult, for example, trauma or infection. Whilst 
aiding in initial bridging of a bone defect site, an excessive host immune response is 
detrimental to wound healing and will impede bone regeneration(Ai-Aql et al., 
2008). The failure of bone bridging will lead to non-union or malunion of mandible 
bone fragments causing significant patient morbidity.   
 
The application of TEC’s for regeneration of a critical-sized bone defect 
requires that the scientific data sets provide the clinician and patient with confidence 
in a viable alternative to current clinical practice by being both reliably efficacious 
and maintaining appropriate patient safety.  Understanding the host immune response 
to a scaffold, from both a morphology and materials point of view, is vital in 
developing an efficacious and biocompatible therapeutic option for bone 
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regeneration of mandibular critical-sized segmental defects. It is important that an 
implant such as a scaffold invoke a minimal host inflammatory response to optimize 
healing of a bony defect(Ai-Aql et al., 2008).  
 
A prospective alternative to the current surgical management of a bicortical 
mandibular segmental bone defect involves employing a bioinert and biodegradable 
scaffold made from polycaprolactone (PCL). PCL can be implanted in the bone 
defect site, providing mechanical support whilst facilitating tissue regeneration. Over 
time, as tissue healing occurs, the construct is biodegraded by the body resulting in 
bridging of the defect with only regenerated host tissue remaining(Woodruff & 
Hutmacher, 2010). Bone healing following a segmental defect commences with an 
inflammatory reaction which may play a role in initiating the regenerative process 
that eventually results in the reconstitution of bone(Schmidt-Bleek et al., 2012). An 
excessive immune response during the early phase of bone healing disrupts normal 
regenerative process and delays healing, negatively impacting on a potential 
successful outcome(Schmidt-Bleek et al., 2012). Thus, in establishing an effective 
alternative to autologous bone grafting, it is important that the PCL based scaffold 
invoke a minimal host inflammatory response to optimize healing of the critical-
sized defect. 
 
Traditionally animal models employing a tissue construct for the regeneration 
of bone have not been sacrificed until 3-6months post implantation to assess bony 
regeneration(Abukawa et al., 2004; Berner et al., 2013; Berner et al., 2012; Cheng et 
al., 2005; Forriol et al., 2009; Herford & Boyne, 2008a; Reichert, Epari, et al., 2010; 
Reichert et al., 2009a; Ren et al., 2007). Long-term implantation allows significant 
time to pass before assessing scaffold integration and bone regeneration as well as 
being ethically acceptable. These studies have demonstrated the biocompatible 
nature of PCL based scaffolds, which make it a valuable synthetic biomaterial for 
bone regeneration and, along with its biodegradable properties of being resorbed 
over the course of 3-4 years, allows an adequate period for bone healing(Holland & 
Tighe, 1992; Middleton & Tipton, 2000) . Polycaprolactone has been FDA approved 
and when combined with its biocompatibility, slow resorption and mechanical 
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strength makes it an ideal material in the design of medical scaffolds for bone tissue 
engineering.   
 
The acute phase tissue response to in vivo polycaprolactone scaffolds employed 
for bone healing in a sheep model has, to the best of our knowledge, never been 
investigated. A greater understanding of the initial response is important to establish 
the biocompatibility and the influence on surrounding tissue as a guide for future 
mineralisation(Cipitria et al., 2012).   
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4.3 MATERIALS AND METHODS: 
 
4.3.1 Scaffold fabrication and preparation 
Biodegradable scaffolds comprising medical grade polycarprolactone (80 kDa) 
(outer diameter 10mm, height 30mm, inner diameter 5mm) was obtained from 
Osteopore (Osteopore International, Singapore). PCL was electropsun using an in-
house device. All scaffolds were treated for 6 hours with 1M NaOH and washed five 
times with phosphate-buffered saline (PBS). Sterilization of the scaffold was 
subsequently performed with the scaffold placed in 70% ethanol (EtOH) for 5 
minutes and under UV irradiation for a minimum of 30 minutes prior to their 
operative implementation. 
 
4.3.2 Surgical Procedure 
Merino sheep (weight 44-52kg, age 6-7yrs) underwent operative intervention 
as approved by the University Animal Ethics Committee at the Queensland 
Universirty of Technology, Brisbane, Australia (Ethics number 1000001192). The 
two experimental groups consisted of an empty defect and a scaffold only group. 
 
Sheep were anaesthetized with an intravenous induction of propofol  (4 mg/kg, 
IV) and maintained with 50% oxygen in air, and isoflurane (1%), using a mechanical 
ventilator.  
The sheep were placed supine, following induction of anaesthesia. The 
procedure was performed under sterile conditions. The right hemimandible surgical 
site prepped with iodine povacrylex. A longitudinal incision was made along the 
inferolateral border of the mid to distal mandible approximately 6-8cm in length.  
The subcutaneous tissue was reflected laterally and held with a retractor. The 
periosteum of the mandible was stripped circumferentially from the mental foramen 
to the first premolar, above the diastema, with a periosteal elevator.   
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A mandible reconstruction plate (2.4mm, 10 holes, Synthes UniLock) was 
placed on the inferolateral border of the mandible, torque neutral. All proximal and 
distal screw holes were drilled and the plate temporarily fixed either side of the 
proposed defect site at the diastema of the mandible. 
 
The fixation plate was then removed and saline soaked gauze inserted between 
the bone and soft tissue to avoid damage to the tissue whilst performing an 
osteotomy. The neurovascular bundle exiting the mental foramen was ligated with 3-
0 monocryl. 
 
The bicortical bone defect was created via parallel osteotomies, perpendicular 
to the long axis of the bone, with an oscillating saw (Stryker) under constant 
irrigation with saline solution. Gauze and Surgicel were applied to the bone marrow 
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Figure 11: Overview of the Operative Procedure  
(A) An Incision of inferolateral right hemimandible; (B) Periosteum 
removed; (C) Diastema exposed with the first premolar (straight arrow) and 
mental nerve (*) identified. (D) Defect marked (curved arrow) and plate 
applied, torque neutral. Drill holes performed; (E) Osteotomy site marked 
and performed once plate removed; (F) Plate reapplied following osteotomy; 
(G) & (H) Scaffold cut to the length of the osteotomy and placed in defect; 
(I) wound closure 
 
In the experimental group, the 30mm PCL length was adjusted to fit the defect 
site by trimming it with a scalpel to match the length of the bone defect. It was then 
gently, but firmly, placed in the defect site and the locking plate fixed. The wound 
was closed in two layers with a subcutaneous continuous suture (3-0 monocryl) and 
interrupted skin sutures (4-0 Novafil). 
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4.3.3 Post-operative management 
Antibiotics and analgesia were administered for the first 48hrs post procedure. 
The sheep were administered buprenorphine (Temgesic
®
, 0.3 mg/ml) (0.005 
mg/kg, IV) and ketorolac (Toradol
®
, 30 mg/ml) (0.5 mg/kg, SC) for preventative and 
post-operative bi-modal pain management. All sheep received a prophylactic 
postoperative parenteral antibiotic regimen [ciprofloxacin (200mg/100ml) (5 mg/kg, 
IV); cefazolin (Kefzol
®
 1 gr) (20 mg/kg, IV); gentamicin (80 mg/2ml) (5 mg/kg, IV). 
All animals underwent daily clinical evaluation by a veterinary surgeon. They were 
placed in a pen with the other post-operative sheep and given a soft diet, including 
water-soaked pellets and Lucerne-oaten chaff, for 48 hours before returning to the 
paddock and normal diet.   
 
4.3.4 Radiographic Analysis 
A lateral and craniocaudal radiograph of the sheep’s mandible was performed 
immediately following the procedure and then two weeks following operative 
intervention. In almost all cases (5 of 6), a fracture of the fixation plate was 
immediately identified on radiograph analysis. The animals were subsequently 
euthanized by intravenous injection of sodium pentobarbital. 
 
Figure 12: Initial radiographs  
Initial post-operative radiographs. All radiographs demonstrate an empty 
defect (*) and the plate fixation (arrow). 
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4.3.5 Explantation 
The scaffolds and surrounding tissue from the sacrificed sheep were explanted 
for immunohistochemical analysis. The soft tissue surrounding the mandible was 
removed and the bony mandible explanted. The mandible was divided with an 
oscillating saw along the symphysis between the central incisors creating two 
hemimandibles. 
In two of the five samples from the experimental scaffold group the implanted 
tissue construct was insecurely attached to native bone and unable to be removed 
with adjacent bone tissue, thus losing the in vivo orientation of the scaffold. In the 
three remaining samples, a tenuous attachment to the distal bone at the site of the 
defect was observed. The two empty defect samples were employed as a control arm. 
After the mandible section containing the scaffold or empty defect was 
extracted it was placed in 10% neutral buffered formalin (NBF) for 2 days for tissue 
fixation then transferred to 70% ethanol.  
 
Figure 13: Histology Preparation.  
Explantation of scaffold and distal body of the hemimandible (A). The 
scaffold (straight lines) were tenuously linked to the native mandible (curved 
lines) (B). The explanted scaffold was sectioned along the longitudinal axis 
and prepared for resin samples (C) and sectioned for paraffin (D). 
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4.3.6 Histology/Immunohistochemistry 
 
Following explantation specimens were placed in 10% neutral buffered 
formalin then transferred to 70% ethanol. The specimen was sectioned in the axial 
plane to create superior and inferior samples, assigned either to paraffin or resin 
embedding.  
 
Scaffold samples for paraffin embedding were decalcified in 15% EDTA for 6-
8 weeks at 4oC. They were subsequently sectioned at 5µm using a microtome (Leica 
RM 2265). The slides were deparaffinised with xylene and rehydrated before 
staining with haematoxylin and eosin (Sigma Aldrich) and mounting with Eukitt 
mounting media (Fluka Biochemical, Milwaukee, WI).  
The remaining samples were embedded in methylmethacrylate resin (MMA, 
Technovit 9100 NEU, Heraeus Kulzer, Wehrheim, Germany). Resin samples were 
sectioned at 6µm and stained with Von Kossa/Van Gieson to assess new 
mineralisation and Goldner’s Trichrome to assess cellular details.  
 
Immunohistochemistry was performed on the paraffin sections. They were 
deparaffinised with Xylene and subsequently rehydrated with increasing 
concentrations of ethanol. Immunohistochemical staining employed primary 
antibodies specific to the osteogenic markers osteonectin, osteocalcin, osteopontin 
and type I collagen (Abcam Cambridge, UK), the macrophage markers CD 68  
(Abcam, Cambridge, UK), and an osteoclast marker TRAP (Abcam, Cambride, UK).    
 
4.3.7 Microscopy 
The stained slides were observed under a Zeiss Axio Observer motorized 
microscope (Zeiss, Germany) for cellular details and photographs taken for further 
analysis.  Photos were taken at x20 magnification. 
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4.3.8 Statistical Analysis 
Analysis of the stained slides was performed through the Image J (Schneider, 
C.A., Rasband, W.S., Eliceiri, K.W. "NIH Image to ImageJ: 25 years of image 






Figure 14: Image J analysis.  
(A)-(D). An example of how Image J can be used to quantify histology 
slides, in particular bone mineralization. (A). Native slide without 
modifications. (B) Slide is converted into a grey scale image. (C) The whole 
slide (stained area) is thresholded (the entire tissue area is made red). (D) 
Only the black (positive black staining for bone mineralization) is then 
thresholded (made red).  A percentage of the bone mineralization can then be 
calculated.  (E)-(G). Shows an example of Image J being used to count the 
number of positively stained cells. (E) The stained image. (F). Image J 
converting to grey scale. (G) Image J then counts the number of positively 
stained cells. 
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4.4 RESULTS  
 
4.4.1 Plate fracture 
The unexpected fracturing of the 2.4mm mandible reconstruction plates 
(Synthes, UniLock) was discovered at radiographic assessment two weeks post 
procedure in 7 out of 8 sheep. As such, the 2.4mm mandible reconstruction plate 
used in human surgery is an inadequate fixation device for the sheep mandible. The 
unforeseen plate fracturing resulted in the premature cessation of any further 
procedures with sacrifice of the 2 sheep from the empty defect arm, and the 5 sheep 
from the scaffold arm. It is evident that 2.4mm mandible reconstruction plates are 
unable to tolerate the considerable forces generated during the masticatory cycle of 
ruminants(Martola et al., 2007). The fixation plate complication was not anticipated 
and warrants further investigation prior to establishing the ovine mandibular model, 
currently being undertaken at our institution. All plates fractured between the plate-
hole fixated immediately proximal to the defect site and the adjacent empty plate-
hole within the defect site. This consistency would indicate that the maximal force 
moment is passed through the plate at this point. Whilst the premature fracturing of 
the fixation plates was unfortunate, it presented an opportunity to study early healing 
response to PCL scaffold.   
 
4.4.2 Radiographic Analysis 
Plain radiographs of the sheep mandible were performed at two weeks post 
implantation and demonstrated fracturing of the fixation plate, in 7 out of the 8 
operations, with inferior and ventral displacement of the distal mandibular segment 
of bone. 
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Figure 15: Plain Radiographs  
Radiographs displaying fracturing of the 2.4mm titanium mandible 
reconstruction plate (Synthes UniLock) at the proximal junction and intact 
titanium plates. (A) is a lateral view of the sheep mandible demonstrating the 
proximal fixation of the plate (i) and the segmental bony defect at the 
diastema of the sheep mandible (ii). (B) is a craniocaudal view and 
demonstrates the segmental bony defect (ii) and the distal fixation of the 
plate at the parasymphyseal region of the mandible (iii). (C) is a lateral view 
of the sheep mandible demonstration fracturing of the fixation plate (iv) at 
the junction of the proximal fixation and the empty segmental defect with 
inferior displacement of the distal segment. (D) is a craniocaudal view of the 
same fractured mandible plate (iv) with medial displacement of the distal 
segment. 
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4.4.3 Histology/Immunohistochemistry 
 
The macroscopic overview of the implanted scaffolds revealed the evident 
failure of host bone integration. No resorption of any scaffold had taken place and 
they remained entirely intact in the defect site. Given the proximal fixation plate 
fracturing and short time frame between implantation and explantation, two of the 
scaffold samples failed to integrate with host tissue at all whilst the remaining three 
samples were tenuously linked at the distal margin to the host bone via fibrous tissue. 
The two samples without fixation to host tissue were unable to be analysed due to 
there unknown orientation in the host tissue. Thus, only three samples from the 
scaffold arm could be accurately assessed.  
 
Goldner’s trichrome stain revealed osteoid tissue within the defect site, 
arranged along the struts of the scaffold. In addition, multi-nucleated cells were seen 
clustered together along the PCL struts and within the soft tissue at the proximal end 
of the defect 
 
Figure 16: Goldner’s Trichrome stain of Scaffold and native bone 
The native bone proximal and distal to the scaffold with evidence of osteoid 
(red) and mineralisation (blue) within the struts of the scaffold. 
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The three scaffolds connected with host tissue were decalcified for histological 
examination. Hematoxylin and eosin stain for both the scaffold group and the empty 
defect group revealed connective tissue comprising collagen fibres and fibroblasts 
throughout the defect site. Blood clot was observed consistently on the medial sides 
of the defect, with the lateral sides showing dense fibrous tissue formation.   
 
Positive TRAP, CD68 and OP staining for osteoclasts and macrophages were 
observed in both the proximal and distal areas in the empty defect group, with greater 
staining in the proximal region. Whilst in the scaffold group osteoclasts and 
macrophages were shown in the proximal area only, with no positive staining along 
the struts of the PCL. 
 
Osteonectin (ON) staining for active osteoblasts was quite dense along the PCL 
struts of the scaffold group with some positive stain scattered through the fibrous 
tissue located in the proximal region of the defect. ON positive staining was seen in 
the proximal region only of the empty defect group with no positive staining at the 
distal region.  
 
Type-I collagen, an early non-specific maker for osteoblastic differentiation 
during mineralisation, and Osteocalcin (OC), a late osteogenic marker, were 
demonstrated through the entire scaffold with Osteocalcin showing a predilection 
around the scaffold struts.  
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Figure 17: Overview of stains for the scaffold group and empty defect group  
(A) Hematoxylin and Eosin stain for scaffold group, s (scaffold), Ds (Distal end), 
Px (Proximal end), Md (medial side), Lt (lateral side). Stains B,D,F and H are from 
the proximal defect site. Stains C, E, G and I are from the scaffold strut located 
towards the distal end. J. Hematoxylin and Eosin stain for empty defect group. Stains 
K, M, O and R are taken from the proximal defect site and stains L, N, Q and S are 
from the distal defect site. (B) Positive stain for TRAP. (C) Negative stain for TRAP. 
(D) Positive stain for CD68. (E) Negative stain for CD68. (F) Some positive stain for 
ON. (G) Positive stain for ON along the scaffold strut. (H) Positive stain for OPN. (I) 
Negative stain for OPN. (K) Large positive stain for TRAP. (L) Light positive stain 
for TRAP. (M) Large positive stain for CD68. (N) Light positive stain for CD68. (O) 
Positive stain for ON. (Q) Negative stain for ON. (R) Positive stain for OPN. (S)  
Negative stain for OPN.  





Figure 18: Cell numbers at the proximal and distal defect site. 
(A) Von Kossa staining of a scaffold group demonstrating the proximal and 
distal native bone; (B) comparison with the intraoperative appearance of the 
scaffold in situ and; (C) Von Kossa staining of an empty defect group with 
fibrous tissue linked only to the distal native bone. (D) Cell numbers at the 
proximal end of the defect site. (E) Cell numbers at the distal end of the 
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Figure 19: Cell numbers at the proximal end of the defect site.  
The positive stains were quantified using Image J and results were 
interpreted in graphical format. OP Empty defect group (EDG) have a m= 
301 cells, whilst scaffold group (SG) has a m = 234 cells with positive stain. 
ON the EDG show m= 219 cells, with the SG having m=121 cells. CD68, 
the EDG show m=342 cells and the SG show 163 cells. TRAP, EDG – m= 
12 cells and SG- m=7 cells. 
 
 
Figure 20: Cell numbers at the distal end of the defect site.  
The positive stains were quantified using Image J and results represented in 
graphical format. OP: EDG- m=25 cells, SG- m= 0 cells. ON: EDG- m=8 
cells, SG- m= 105 cells. CD68: EDG – m= 220 cells, SG- m= 0 cells. TRAP: 
EDG – m=3 cells, SG- m= 0 cells. 
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Undecalcified sections were resin embedded (MMA) and stained with Von 
Kossa / Van Gieson to get an entire overview of the defect site. This enabled host 
bone plus the defect/scaffold to be visualised in one histological slice with resin able 
to embed very large bone samples. In addition, it allowed observation and 
assessment of bone mineralisation. Both groups showed mineral deposition 
throughout the centre of the defect site. Despite the limited implantation time, the 
scaffold group (n=3) showed an average of 3.4 % mineralization across the whole 
defect site and the empty defect (n=2) showed mineralization of 0.5% across the 




Figure 21: Whole resin sections 
A.  Schematic of the tissue sections indicating the host bone (b) and the 
location of the scaffold (s) within the sections. B. Von Kossa / Van Gieson 
stain to show bone mineralization (Black stain). Black lines indicate host 
bone (which was not included when calculating bone mineralization). C. 
Goldner’s Trichrome stain used to identify osteoblasts (red with Golgi 
complex pint), osteoclasts (light red), osteoid (orange-red), cartilage 
(purple), nuclei (blue-grey) and mineralised bone (Dark green).  D. Positive 
osteoclast staining (light red, multi-nucleated cells) around the struts at the 
proximal end of the defect site.  
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Figure 22: Bone mineralization seen in Von Kossa staining.   
The percentage of bone mineralization calculated from Image J presented in 
a graph. The scaffold group (n=3) show a significant number bone 
mineralization (m=3.4%)  (p=  compare to the empty defect group (n=3) (m= 
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4.5 DISCUSSION 
Bone healing following bicortical disruption commences with an inflammatory 
reaction which initiates the regenerative process that may eventually result in the 
reconstitution of bone(Schmidt-Bleek et al., 2012). Bone is unique in connective 
tissue healing because it heals entirely by cellular regeneration and the production of 
a mineral matrix rather than just collagen deposition, known as scar(Marx, 2007). An 
excessive immune response during the early phase of bone healing disrupts the 
normal regenerative process and may delay healing, negatively impacting on a 
potentially successful outcome(Schmidt-Bleek et al., 2012). Therefore, a greater 
understanding of the acute host response is pivotal when designing and optimizing a 
tissue engineered scaffold system in bone healing. In our pilot study of a large 
segmental mandible sheep model (LSMSM), the premature fracturing of fixation 
plates was an unexpected adverse event. Nonetheless, it provided an opportunity to 
examine the early stages of the host response to the polycaprolactone (PCL) scaffold 
construct. 
 
Plain radiographic assessment revealed the unexpected adverse event of plate 
fracturing in most procedures (7 out of 8).  Early callous formation could not be 
discerned radiographically at 2 weeks post implantation, in keeping with an unstable 
fracture and the early time point of the investigation. The distal fracture fragment 
displayed inferior and ventral displacement as expected with attachment of the 
prominent masseter muscle to the body and ramus of the mandible. This large muscle 
attachment would be expected to produce dorsal and superior displacement of the 
proximal segment. We also undertook micro-CT analysis but could not detect any 
mineralisation at only three weeks implantation (data not shown). Titanium plate 
fracturing occurred at the proximal position of the defect site between the final 
screw-hole of proximal fixation and the first empty screw-hole of the defect site, 
indicating that the maximal load and moment forces of mastication are occurring at 
this point of the plate. It is evident that 2.4mm mandible reconstruction plates 
(Synthes UniLock), used in human surgery, is an inadequate fixation device for the 
sheep mandible as they are unable to tolerate the considerable forces generated 
during the masticatory cycle of ruminants(Martola et al., 2007). The biomechanics of 
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the sheep jaw are unique and warrant the adoption of alternate fixation devices for 
future research endeavours. The fixation plate complication was not anticipated and 
warrants further investigation prior to establishing the large segmental defect 
mandible sheep model. Whatever plate fixation system is employed, it will require 
rigorous biomechanical testing prior to implementation, a process being undertaken 
in our group at present. 
 
Histology and immunohistochemistry results have reinforced the 
biocompatible nature of the PCL based scaffold and highlight the capacity of the 
scaffold system in providing a platform for cells promoting a regenerative pathway, 
such as osteoblasts and fibroblasts, to result in organised fibrous tissue deposition, a 
decreased immune response and enhanced bone mineralization potential compared to 
that of the empty defect group. The markers of the acute phase inflammatory 
response are observed in both empty defect (ED) and scaffold (S) groups 
predominantly at the proximal defect, site of the fixation plate fracturing, with 
minimal staining along the PCL struts.   
 
Macrophages are a heterogeneous subset of the mononuclear cell population, 
activated in response to tissue damage and infection, involved in the host response to 
implanted materials such as polycaprolactone (Brown, Valentin, Stewart-Akers, 
McCabe & Badylak, 2009). There is an association between the early macrophage 
response to implanted materials and the outcome of tissue remodelling with the 
tissue healing outcome ranging from scarring to healthy functional tissue formation 
suggesting a central, and perhaps determinant, role for macrophages in tissue 
remodelling(Badylak, Valentin, Ravindra, McCabe & Stewart-Akers, 2008; Brown 
et al., 2009). In this study the macrophage lineage cells are observed mostly at the 
site of fixation plate fracture, consistently being the proximal end of the defect 
(m=163 cells/field for scaffold group and m=342 cells/field for empty defect group).  
The macrophage population contained numerous multi-nucleated cells with the 
correlating TRAP stain much lower (7-12 cells per field) in both groups, indicating 
the remaining multi-nucleated cells are likely foreign-body giant cells, created by the 
fusion of macrophages and a likely response to the presence of a foreign body such 
as the fractured titanium plate. The presence of large numbers of tissue macrophages 
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and their multinucleate giant-cell counterpart is one of the hallmarks of chronic 
inflammation(Badylak et al., 2008). The macrophage and multinucleate giant-cell 
population in the proximal defect site of the scaffold group was almost half that of 
the empty defect group providing a lower probability of initiating a chronic 
inflammatory reaction. At the distal end of the defect site a lower number of 
macrophage cells are observed in both groups (ED m = 220 cells /field and SG m=0 
cells/field). Firstly and foremost, this demonstrates the biocompatible nature of the 
PCL based scaffold, which has not stimulated a proinflammatory response. Secondly, 
with the macrophage cells predominantly at the proximal defect site in both groups it 
is likely that the fractured titanium plate has produced a foreign body reaction, 
influencing the recruitment of cells of the macrophage lineage in the acute immune 
response.  
 
The scaffold group did not demonstrate macrophages along the scaffold struts 
or in the distal defect with TRAP, CD68 and OP staining demonstrated only at the 
proximal site of the scaffold group. The minimal inflammatory reaction 
demonstrated within the scaffold group, with an absence of osteoclasts and 
macrophages, highlights the bioinert nature of the PCL based scaffold but may also 
be a result of the provision of mechanical stability provided by the scaffold across 
the defect site, potentially limiting the inflammatory response.  Mechanical stability 
at a wound site is critical in wound healing as it may alter mesenchymal stem cell 
differentiation by influencing the degree of angiogenesis at the wound site(Le, 
Miclau, Hu & Helms, 2001; Marsh & Li, 1999). Von Kossa staining revealed 
evidence of blood vessel formation along the PCL struts implying a provision for 
angiogenesis. This improves bone healing potential as it has been shown that 
compromised angiogenesis at unstable fracture sites may induce osteoblasts to 
produce fibrous tissue instead of bone(Remedios, 1999). Thus, by providing a degree 
of mechanical stability in the microenvironment and a framework for cellular 
regeneration the scaffold may organize the tissue response during healing, restraining 
the immune response, encouraging angiogenesis and in turn assisting bone 
regeneration.  
 
 72 Chapter 4: Histology: 
Osteoid and fibrous tissue aligned along the struts of the scaffold with the 
marker for activated osteoblasts, osteocalcin (OC), also exhibiting a predilection for 
the scaffold struts. The appearance is of the scaffold providing a pathway for 
organised fibrous tissue and subsequent cellular regenerative response. Studies 
employing a longer implantation period have previously demonstrated that a scaffold 
design can guide fibrous tissue formation in a controlled manner(Cipitria et al., 
2012). The scaffold group demonstrated not only organised fibrous tissue deposition 
but also an overall increase in the markers of early and late osteoblastic 
differentiation, namely osteonectin (ON), osteocalcin (OC) and Collagen-I. The 
expression rate of osteocalcin and osteonectin has been shown to directly correspond 
to crystal formation and mineralisation implying the scaffold group possesses greater 
bone mineralisation potential than the empty defect group (Collin et al., 1992; 
Hauschka, 1986; Meyer et al., 1999).  These markers for early and late osteoblastic 
differentiation were predominantly along the PCL scaffold struts, indicating the 
important role the scaffold performs in organization the cellular response. The 
provision of a framework guiding tissue healing was demonstrated recently by 
Cipitria et al, who surmised the scaffold acts as supporting substrate for organised 
fibrous tissue deposition prior to mineralisation(Cipitria et al., 2012). Whilst both 
groups demonstrated mineralisation within the defect site, the average mineralisation 
of the scaffold group (3.4%) was greater than the empty defect group (0.5%) even 
after only three weeks implantation. Thus, findings are congruous with previous 
studies indicating the PCL scaffold provided the framework for an organised cellular 
response from an early stage with a combination of decreased inflammatory markers, 
organised osteoid and greater osteoblastic differentiation markers. It illustrates that 
the scaffold system may influence bone regeneration from the acute phase by 
limiting the initial inflammatory phase of healing whilst also demonstrating a 
significant increase in bone mineralization potential compared to the empty defect 
group. 
 
Resolution of the plate fixation system for a large segmental mandible sheep 
model is imperative for future studies evaluating tissue engineered constructs used in 
regenerative repair. Whether the solution is a thicker fixation plate or an innovative 
plate fixation design, it will require further scrutiny including biomechanical testing 
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prior to implementation and is currently being undertaken in our group. Whilst the 
plate fracturing was an unexpected adverse event it opened a unique opportunity to 
investigate the early acute phase tissue response to an in vivo polycaprolactone 
scaffold employed for bone healing in a sheep model, which has, to the best of our 
knowledge, never been investigated. Our early time point results indicate that the 
PCL based scaffold’s ability to provide a framework for an organised fibrous tissue 
network may occur from the initiation of the inflammatory response phase of wound 
healing, even in an unstable fracture environment. The macrophage response in both 
groups was principally at the site of plate fracturing and likely influenced by the 
“foreign body” nature of the plate fracture with a distinctly reduced response in the 
scaffold group. Results suggest that after only three weeks following osteotomy, the 
scaffold struts have provided a platform for cells promoting a regenerative pathway, 
such as osteoblasts and fibroblasts. The fibrous tissue network is vital in guiding 
future mineralization, and has been shown to influence the microstructure of newly 
formed bone(Cipitria et al., 2012). The PCL scaffold displayed greater bone 
mineralisation as compared to the empty defect group after only three weeks in vivo. 
The results provide further evidence that a PCL construct invokes a minimal host 
inflammatory response and by providing mechanical stability and a framework for 
cellular regeneration may promote organized tissue healing with a restrained immune 
response, encouraging angiogenesis and increasing bone mineralisation potential that 
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Chapter 5: Conclusions and Future Work 
The human mandible is a unique bone occupying a position of prominence and 
vulnerability(Gray, 2000). Segmental bone defects of the mandible are destructive 
and cause significant impediment to normal function and aesthetics as well as being 
technically difficult to reconstruct(Hollinger & Kleinschmidt, 1990). The current 
clinical gold standard for reconstruction of segmental bone defects is the application 
of autologous bone grafting, as they possess excellent osteoconductive and 
osteoinductive properties(Ekholm et al., 2006). However, the limitations of 
autologous bone grafts range from inadequate quantity and quality of bone, to the 
morbidity of a second operative site(Boyne, 1997; Schmidmaier et al., 2009). In 
addition, the failure rate of autologous bone graft is up to 30%(Gautschi et al., 2007). 
These complications are avoidable with the development of an “off the shelf”, ready 
to use construct possessing superior osteoinductive and osteoconductive properties, 
alleviating the requirement of a second operative site. By applying tissue engineered 
constructs (TECs) of synthetic or natural biomaterials that promote the migration, 
proliferation, and differentiation of bone regenerative cells, surgeons can overcome 
the problems posed by autologous bone grafting (Petite et al., 2000). Returning the 
patient to normal oral function whilst limiting patient morbidity and avoiding the 
need for re-intervention will provide the patient with a better quality of life(Bak et 
al., 2010; Schrag et al., 2006). This provides the rationale for translational research 
into viable therapeutic alternatives that are easy to handle, restore facial form, 
speech, function and occlusion, providing effective management at the initial 
operative intervention (Bak et al., 2010; Gautschi et al., 2007; Schrag et al., 2006). A 
prospective alternative to the current surgical management of a bicortical mandibular 
segmental bone defect involves employing a bioinert and biodegradable scaffold 
made from polycaprolactone (PCL). PCL can be implanted in the bone defect site, 
providing mechanical support whilst facilitating tissue regeneration. Over time, as 
tissue healing occurs, the construct is biodegraded by the body resulting in bridging 
of the defect with only regenerated host tissue remaining(Woodruff & Hutmacher, 
2010). The application of TEC’s for regeneration of a critical-sized bone defect 
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requires that the scientific data sets provide the clinician and patient with confidence 
in a viable alternative to current clinical practice by being both reliably efficacious 
and maintaining appropriate patient safety.  The realisation of a safe and viable 
alternative in the surgical management of segmental mandible defects is of 
significant clinical implication. 
 
A review of the literature highlighted the need for greater data on the efficacy 
and safety profile for novel approaches to healing mandible continuity defects prior 
to their translation to the human condition and clinical implementation. The disparate 
approaches in investigating mandible defect bone regeneration has resulted in many 
animal models and case-reports but often a lack of depth and reproducibility in 
scientific data sets. Currently, preclinical and clinical evidence for more widespread 
indications and applications of newly developed tissue engineering techniques is 
unclear and has not yet undergone sufficient rigorous scientific investigation to 
warrant widespread adoption(Bell & Gregoire, 2009; Carter et al., 2008b; Glied & 
Kraut, 2010b). For novel approaches in mandible bone defect regeneration to be 
translated from the bench top to the bedside requires vigorous in vivo interrogation 
through a well-designed and validated preclinical animal model. The collation of a 
reliable and reproducible body of research in preclinical animal model requires the 
establishment of a standardized large animal model, an imperative step in 
translational research of a tissue engineered construct (TEC). The standardized 
animal model must be consistent in the animal’s age and breed, the operative 
technique, post-operative care, and finally the post-explantation analysis. The model 
will provide reproducible and relevant data sets required for comprehensive 
investigation of novel tissue engineering approaches in reconstructing mandible 
segmental defects. It will permit rigorous assessment of alternate techniques to 
current clinical practice so that they can be reliably efficacious when applied in the 
operating theatre whilst maintaining appropriate patient safety.  
 
The literature demonstrates that a variety of animal models have been 
employed in the investigation of mandible defect regeneration but there has yet to be 
consistency in developing a standardized systematic approach.  Whilst there can be 
no perfect animal model, on review of the current literature and invoking prior 
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practical experience with sheep tibial segmental defect projects, we propose that 
sheep provide the most advantageous large animal model for translational studies to 
assess the safety and efficacy of a mandibular tissue engineering construct 
(TEC)(Abu-Serriah et al., 2006; Abu-Serriah et al., 2005; Berner et al., 2013; Berner 
et al., 2012; Cheng et al., 2005; Hutmacher et al., 2001; Reichert, Epari, et al., 2010; 
Reichert et al., 2009a; Reichert, Woodruff, et al., 2010). Our line of reasoning 
follows that sheep are closer to humans in the phylogenetic tree, easy to handle, 
possess a readily accessible mandibular site that is a similar size and has similar bone 
formation to humans and respond well to surgical procedures(den Boer et al., 1999; 
Pearce et al., 2007; Reichert et al., 2009a; Salmon & Duncan, 1997; Wittenberg et 
al., 1997). Through a pilot study to assess practicality, we verified that a standardized 
large segmental mandible sheep model (LSMSM) is effectual and offers the suitable 
framework from which additional experimentation and evaluation of novel TEC’s 
may be undertaken, compared and collated.  It will provide the necessary data sets 
required in the assessment of current and future novel approaches to mandible 
segmental defect reconstruction that may be transferable to the human condition and, 
ultimately, the operative table. 
 
The pilot study we conducted to establish a large segmental mandible sheep 
model (LSMSM) provided the framework for generating relevant, reproducible data 
sets in assessing bone healing. It is important that relevant data sets be generated, 
correlated and applied to future research to provide a growing body of knowledge of 
novel TECs that will permit their translation and implementation to clinical practice. 
The LSMSM framework involves;  
i) Establishing the critical-sized defect;  
ii) Standard operative technique with appropriate construct application 
and fixation prostheses;  
iii) Post-operative management involving diet, antibiotics and analgesia; 
iv) Regular clinical and radiographic review; 
v) Scaffold implantation timeframe and explantation; and  
vi) Post-explantation analysis   
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a. Biomechanical testing,  
b. Immunohistochemistry, and  
c. µ (micro)-CT analysis.  
 
The tenets of this process have been well established at our institution with the 
sheep tibial defect model to provide relevant data sets in bone healing and the pilot 
study we performed established that the process is equally relevant and applicable to 
the sheep mandible defect model(Berner et al., 2013; Berner et al., 2012; Hutmacher, 
2001; Reichert, Epari, et al., 2010; Reichert et al., 2009a; Reichert, Woodruff, et al., 
2010; Reichert et al., 2011).  
 
The primary stumbling block of our current research was the unexpected 
fracturing of the titanium fixation plates resulting in is the instability across the 
defect site. The surgical management of mandibular body fractures in the clinic is 
principally open reduction and internal rigid fixation (ORIF). This allows rapid 
osseous repair, with return of occlusion and masticatory function and maintenance of 
periodontal tissue(Korkmaz, 2007; Olate et al., 2013). ORIF approach to human 
mandible body fractures is primarily achieved with 2.0mm and 2.4mm titanium 
mandible reconstruction locking or standard plates(Collins et al., 2004; Korkmaz, 
2007; Olate et al., 2013; Scolozzi & Richter, 2003; Shaik et al., 2012) The 2.4mm 
titanium reconstruction plates used to treat severe mandibular fractures demonstrate 
successful stabilisation with a low rate of major complications (3%)(Scolozzi & 
Richter, 2003). To mimic the clinical environment and in light of the Sheep ruminant 
masticatory pattern it was decided that the robust 2.4mm titanium mandible 
reconstruction plates (Synthes UniLock) would be used for fixation in our pilot 
LSMSM. It must be noted that in the human clinical condition ORIF is often 
employed in conjunction with maxillomandibular fixation, which is not feasible in an 
animal model(Collins et al., 2004; Korkmaz, 2007; Olate et al., 2013; Shaik et al., 
2012). In addition, the sheep mandible provides a unique challenge in the operative 
and post-operative management of a segmental defect given the crucial role it plays 
in mastication and the ruminant digestive system. This resulted in fracturing of 9 out 
of 12 of the 2.4mm titanium mandible reconstruction plates (Synthes UniLock) 
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employed in the pilot study. Failure of the titanium locking plates proved to be a 
significant impediment to assessing the efficacy of our polycaprolactone (PCL) 
scaffold in bone regeneration of a segmental mandibular defect. Plate fracturing is 
encountered in the human clinical setting, though rarely published(Collins et al., 
2004; Doty et al., 2004; Esen, Ataoglu & Gemi, 2008; Katakura et al., 2004). The 
cause of plate fracture is thought to be the result of stress concentration. The location 
of a plate fracture will vary and depend on the type of fixation plate and the position 
of fixation, requiring frequent repeated application of stress or fatigue at a particular 
site(Katakura et al., 2004). Evaluation of clinical and experimental plate fracture 
among cases in which primary reconstruction after mandibular resection employed 
titanium plates revealed that plate fracturing was commonly in L-type defect cases in 
which angle-type plates were used, and the fracture mainly occurred in the anterior 
region of the mandibular angle(Katakura et al., 2004). Instability at a defect site is 
not conducive to bone formation and bridging of the defect(Giannoudis et al., 2007). 
Thus in the clinical application of a bone graft in a mandibular segemental defect, 
instability at the plate fracture site often resulted in bone graft failure(Futran et al., 
1995; Hidalgo, 1989; Mooren et al., 2010; Yerit et al., 2002). To correctly assess 
bone healing following the application of a novel TEC will require adequate 
stabilisation of the mandible segmental defect site. 
 
The obvious difficulty associated with the post-operative care of the LSMSM 
is the inability to limit post-operative mobility of the mandible. As ruminants, it is 
important that sheep return to a normal diet as soon as possible. It was noted during 
the pilot study that sheep grind their teeth immediately following extubation and 
during recovery following anaesthesia. In addition, the mechanics of sheep 
mastication are such that they possess large masseter muscles and generate large 
amounts of torque during mastication. As such, the 2.4mm titanium mandible 
reconstruction plates (Synthes UniLock) used in human mandible surgery have been 
shown to be inadequate fixation devices for the sheep mandible and this 
complication must be overcome prior to proceeding with future research and 
implantation of a TEC. It will require a fixation device that affords strength and 
stability immediately upon application to manage early force from the immediate 
recovery phase of anaesthesia. Further investigation and design into providing a 
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viable fixation plate substitute for the sheep model is currently being performed. We 
hypothesized that thicker mandible reconstruction plates with longer screw lengths at 
the symphysis that engage the contralateral mandible or a purpose-designed plate 
may provide the fixation able to withstand the masticatory forces achieved in the 
sheep mandible and alleviate this predicament, allowing the sheep to initiate 
immediate mastication post-operatively.  
 
 
Figure 23: Customised stainless steel plates that will be biomechanically tested 
 
Whilst mimicking the clinical setting completely is ideal in translational 
research, no animal model is perfect. In this study, it has been established that the 
application of 2.4mm titanium reconstruction plates are inadequate in the sheep 
mandible model despite the ubiquitous use in both the literature and clinic for 
fixation of large mandibular segmental defects(Carter et al., 2008a; Clokie & S·ndor, 
2008; Glied & Kraut, 2010a; Herford & Boyne, 2008a).  Biomechanical testing is 
currently being performed on the unoperated hemimandibles (i.e. the left 
hemimandible) to establish the force required for stable fixation of a segmental 
mandible defect.  Testing of alternate fixation plates, ranging from 2.4mm titanium 
mandible reconstruction plate, 2.8mm titanium mandible reconstruction plate and 
custom made stainless steel fixation plate will establish the most appropriate fixation 
system that can be implemented into the LSMSM. Early results suggest that the 
titanium mandible reconstruction plates, whilst satisfactory for clinical application, 
will not provide adequate stabilisation of a segmental mandible defect in the sheep 
model (data not shown). Successful stabilisation across the defect site is likely to 
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require the application of a customised, stainless steel fixation plate as shown in 
Figure 20. Stability and reliability of the fixation plate system is crucial and the 
operative technique required to apply the custom plate will be analogous to that 
experienced in the clinical setting. It does not require an additional skills subset and 
is easy to handle intra-operatively, similar in application to the titanium fixation plate 
system. Importantly, once plate stability is achieved, the critical-sized defect can be 
established for our model and data sets for long-term implantation of novel TEC’s 
can be attained, rigorously assessed and compared. 
 
The premature fracturing of the fixation plates was unexpected but provided a 
unique opportunity to examine the early stages of the host response to a 
polycaprolactone (PCL) scaffold construct.  Histology and immunohistochemistry 
results have reinforced the biocompatible nature of the PCL scaffold providing 
further evidence that a PCL-based construct invokes a minimal host inflammatory 
response. The PCL scaffold displayed a more organised and reduced immune 
response with significantly greater bone mineralisation as compared to the empty 
defect group after only three weeks in vivo. This result is congruent with recent 
studies suggesting the scaffold provides a framework for the initial fibrous tissue 
deposition prior to mineralisation(Cipitria et al., 2012). The scaffold has provided the 
framework for organised fibrous tissue and cellular response from an early stage with 
a combination of decreased inflammatory markers, structured fibrous deposition and 
increased osteoid production with early bone mineralisation. By providing 
mechanical stability and a framework for cellular regeneration, scaffolds have been 
shown to promote organized tissue healing, restraining the immune response and 
encouraging structured bone regeneration(Cipitria et al., 2012). Our unique early 
time point study indicated that the importance of the scaffold system in providing a 
platform for cells promoting a regenerative pathway, such as osteoblasts and 
fibroblasts, occurs in the initial phases of wound healing. This structured response 
may lead to organised fibrous tissue deposition, a decreased immune response and 
enhanced bone mineralization potential that should result in enhanced wound 
healing. Future studies in the LSMSM will employ a longer implantation time and 
the subsequent histological analysis will provide data assessing later stages of wound 
healing including the adequacy of bone remodeling. 
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The post-operative management employed in the pilot study was practicable 
and suitable. Sheep, being ruminants, must be returned to a full diet as soon as 
possible. As stated earlier, it was noted in the pilot study that sheep grind their teeth 
immediately following extubation, during recovery following anaesthesia. The 
provision of a robust fixation plate system must allow the sheep to commence 
mastication immediately post-operatively. Regular analgesia and antibiotics were 
appropriate and it is noted that the sheep did not loose any weight between the 
operative dates till the time of sacrifice. However, it is difficult to ascertain exactly 
when fixation plate fracturing occurred as no radiographic evidence was available till 
three weeks post-operative. In addition, no polymorphonuclear leukocytes were 
observed in histology, nor clinical signs of infection evident in any sheep, suggesting 
appropriate sterilisation and operative technique and adequate antibiotic therapy was 
employed. 
 
Post-explantation analysis has been appropriately designed to provide data sets 
that are both reproducible and relevant. Whilst the pilot study was concluded 
prematurely with only a short time frame of scaffold implantation due to fixation 
plate fracture, the framework for relevant, reproducible data sets was successfully 
established. This includes the regular radiographic assessment of live sheep and 
micro-CT analysis of explanted defects, both of which were performed during this 
study. Unfortunately, due to the short time frame of implantation, almost no 
mineralisation was observed in the defect site with absence of bone bridging, thus the 
micro-CT did not produce any data. The slide preparation and subsequent 
histological analysis was relevant and significant with further analysis of bone 
mineralisation and remodelling to be performed in long term implantation studies. 
The embedding technique for biomechanical testing and loading analysis of 
explanted hemi-mandibles has been established, currently producing relevant data to 
assess and compare alternate plate fixation systems for use in future studies. Future 
studies will employ all of the above tenets of the post explantation analysis to 
provide the relevant preclinical data required to evaluate the safety and efficacy of 
novel TECs prior to clinical implementation.  
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The LSMSM provides an excellent model for both operative intervention and 
post-operative management and investigation of TECs once the limitation of the 
premature fixation plate fracturing is overcome. Whilst the premature fracturing of 
fixation plate was an unforeseen setback, the pilot study reinforced the advantages of 
standardized sheep model for translational research on mandible segmental defect 
regeneration. It offers the most suitable framework from which additional 
experimentation and evaluation of novel TEC’s may be undertaken, compared and 
collated to provide the necessary data sets required in the assessment of current and 
future novel approaches to mandible segmental defect reconstruction that may be 
transferable to the human condition and, ultimately, the operative table. The ability to 
compose PCL-based rapid prototype TECs with fused deposition modelling may 
result in customized scaffolds made to defect specifications. This ability provides 
many options for therapeutic application from larger defects, including hemi- or full 
mandible reconstructions to embedding with osteoinductive and osteoconductive 
factors and stem cells to assist regeneration. Establishing an effective model will 
generate the framework for further research comparing novel approaches to large 
segmental mandible defects and solving complicated therapeutic problems ranging 
from even larger segmental mandible defects to bone regeneration in a difficult 
clinical setting such as a tumour model with post-irradiated, poorly vascularised 
tissue. These extraordinary but achievable goals will provide the inspiration to 
further the research. 
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